VISHAY INTERTECHNOLOGY INC
For the period ended Dec 31, 2025. Filed Feb 13, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 13, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to the Consolidated Financial Statements
Vishay Intertechnology, Inc. (“Vishay” or the “Company”)manufactures one of the world’s largest portfolios of discrete semiconductors and passive electronic components that are essential to innovative designs in the automotive, industrial, military, aerospace, healthcare, power supplies, telecommunications, consumer products, and computing end markets. Semiconductors include MOSFETs, diodes, and optoelectronic components. Passive components include resistors, inductors, and capacitors.
Note 1 – Summary of Significant Accounting Policies
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ significantly from those estimates.
Principles of Consolidation
The consolidated financial statements include the accounts of Vishay and all of its subsidiaries in which a controlling financial interest is maintained. For those consolidated subsidiaries in which the Company’s ownership is less than 100 percent, the outside stockholders’ interests are shown as noncontrolling interests in the accompanying consolidated balance sheets. Investments in affiliates over which the Company has significant influence but not a controlling interest are carried on the equity basis. Investments in affiliates over which the Company does not have significant influence are accounted for by the cost method. All intercompany transactions, accounts, and profits are eliminated.
Revenue Recognition
The Company recognizes revenue from contracts with customers when it satisfies the performance obligations within the contract. The Company has framework agreements with many of its customers that contain the terms and conditions of future sales, but do not create enforceable rights or obligations. For revenue recognition purposes, the Company considers the combined purchase orders and the terms and conditions contained within such framework agreements to be contracts.
Payment terms for the Company's sales are generally less than ninety days. Substantially all of the Company's receivables historically have been and are expected to continue to be collected within twelve months of the transfer of products to the customer and the Company expects this to continue going forward. Accordingly, the Company does not recognize a financing component of the transaction price.
Revenue is measured based on the consideration specified in contracts with customers, and excludes any sales incentives and amounts collected on behalf of third parties. The Company recognizes revenue when it satisfies its performance obligations. The Company analyzes its contracts to determine whether the promise in the contract to construct and transfer goods to the customer is a performance obligation that will be satisfied over time or at a point in time. When the Company's performance does not create an asset with an alternative use to the Company and the Company has an enforceable right to payment for performance completed to date, the Company transfers control of a good or service over time and, therefore, satisfies a performance obligation and recognizes revenue over time. The Company has a limited number of contracts for custom products that meet the criteria to recognize revenue over time.
The Company's contracts containtwo performance obligations: delivery of products and warranty protection. The Company does not sell separate, enhanced, or extended warranty coverage, but through its customary business practices, the Company has created implied service-type warranties, which are accounted for as separate performance obligations. Revenue is allocated between these two performance obligations and recognized as the obligations are satisfied. The allocation of revenue to warranty protection is based on an estimate of expected cost plus margin. The delivery of products performance obligation is satisfied and product sales revenue is recognized when the customer takes control of the products. Warranty revenue is deferred and the warranty protection performance obligation is satisfied and revenue is recognized over the warranty period, which is typically less than twenty four months from sale to end customer. The warranty deferred revenue liability is recorded within Other Accrued Expenses and Other Liabilities on the accompanying consolidated balance sheets. The deferred revenue balance associated with the service-type warranty performance obligations and the components that comprise the change in the deferred revenue balance are not significant.
The Company has a broad line of products that it sells to original equipment manufacturers ("OEMs"), electronic manufacturing services ("EMS") companies, which manufacture for OEMs on an outsourcing basis, and independent distributors that maintain large inventories of electronic components for resale to OEMs and EMS companies.
The Company recognizes revenue on sales to distributors when the distributor takes control of the products ("sold-to" model). The Company has agreements with distributors that allow distributors a limited credit for unsaleable products, which it terms a "scrap allowance." Consistent with industry practice, the Company also has a "stock, ship and debit" program whereby it considers requests by distributors for credits on previously purchased products that remain in distributors' inventory, to enable the distributors to offer more competitive pricing. In addition, the Company has contractual arrangements whereby it provides distributors with protection against price reductions initiated by the Company after product is sold by the Company to the distributor and prior to resale by the distributor.
The Company recognizes the estimated variable consideration to be received as revenue and records a related accrued expense for the consideration not expected to be received, based upon its estimate of product returns, scrap allowances, "stock, ship and debit" credits, and price protection credits that will be attributable to sales recorded through the end of the period. The Company makes these estimates based upon sales levels to its distributors during the period, inventory levels at the distributors, current and projected market conditions, and historical experience under the programs. The Company utilizes a number of different methodologies and considers several factors when estimating the accruals. Some of the factors considered include sales levels to distributors during the relevant period, inventory levels at the distributors, current and projected market trends and conditions, recent and historical activity under the relevant programs, changes in program policies, and open requests for credits. These procedures require the exercise of significant judgments. The Company believes that it has a reasonable basis to estimate future credits under the programs. See sales returns and allowances accrual activity in Note 9.
The Company pays commissions to external sales representatives on a per-sale basis. Accordingly, these commissions are expensed as incurred because the future amortization period of the asset that the Company otherwise would have recognized is one year or less. Internal staff are not paid commissions.
The Company has elected to account for shipping and handling as activities to fulfill the promise to transfer the product even if the shipping and handling activities are performed after the customer obtains control. The Company does not evaluate whether shipping and handling activities are promised services to its customers. If control transfers and revenue is recognized for the related products before the shipping and handling activities occur, the related costs of those shipping and handling activities is accrued. The Company applies this accounting policy election consistently to similar types of transactions.
See disaggregated revenue information in Note 15.
Research and Development Expenses
Research and development costs are expensed as incurred. The amount charged to expense for research and development (exclusive of purchased in-process research and development) aggregated $122,388, $120,126, and $99,506, for the years ended December 31, 2025, 2024, and 2023, respectively. The Company spends additional amounts for the development of machinery and equipment for new processes and for cost reduction measures.
The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Deferred taxes result from differences between the financial and tax bases of the Company’s assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances have been established for deferred tax assets which the Company believes do not meet GAAP criteria of “more likely than not” to be realized. This criterion requires a level of judgment regarding future taxable income, which may be revised due to changes in market conditions, tax laws, or other factors. If the Company’s assumptions and estimates change in the future, valuation allowances established may be increased, resulting in increased tax expense. Conversely, if the Company is ultimately able to utilize all or a portion of the deferred tax assets for which a valuation allowance has been established, then the related portion of the valuation allowance can be released, resulting in decreased tax expense.
The Company and its subsidiaries are subject to income taxes in the U.S. and numerous foreign jurisdictions. Significant judgment is required in evaluating the Company’s tax positions and determining its provision for income taxes. During the ordinary course of business, there are many transactions and calculations for which the ultimate tax determination is uncertain. The Company establishes reserves for tax-related uncertainties based on estimates of whether, and the extent to which, additional taxes will be due. These reserves are established when the Company believes that certain positions might be challenged despite the Company’s belief that its tax return positions are fully supportable. The Company adjusts these reserves in light of changing facts and circumstances and the provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate.
These accruals for tax-related uncertainties are based on management’s best estimate of potential tax exposures. When particular matters arise, a number of years may elapse before such matters are audited by tax authorities and finally resolved. Favorable resolution of such matters could be recognized as a reduction to the Company’s effective tax rate in the year of resolution. Unfavorable resolution of any particular issue could increase the effective tax rate and may require the use of cash in the year of resolution. The amount included in current liabilities on the accompanying consolidated balance sheets reflect only amounts expected to be settled in cash within one year.
See Note 5.
Cash, Cash Equivalents, and Short-Term Investments
Cash and cash equivalents includes demand deposits and highly liquid investments with maturities ofthree months or less when purchased. Highly liquid investments with original maturities greater than three months, but less than one year are classified as short-term investments. At December 31, 2025 and 2024, the Company’s short-term investments were comprised of time deposits with financial institutions whose original maturity exceeds three months, but less than one year.
Accounts Receivable and Allowance for Credit Losses
The Company estimates its credit losses on financial instruments using a current expected credit loss model. The Company maintains an allowance for accounts receivable credit losses resulting from the inability of its customers to make required payments. Payment terms for the Company's sales are generally less than ninety days. Substantially all of the Company's trade receivables are collected within twelve months of the transfer of products to the customer and the Company expects this to continue going forward. The credit loss allowance is determined through an analysis of the aging of accounts receivable and assessments of risk that are based on historical trends and an evaluation of the impact of current and projected economic conditions. Receivables from customers with deteriorating financial condition and those over 180 days past due are removed from the pool and evaluated separately. Net credit loss expense (benefit) for accounts receivable was$911, $(214), and $369 for the years ended December 31, 2025,2024, and 2023, respectively.
The Company’s cash equivalents, short-term investments, and restricted investments are accounted for as held-to-maturity debt instruments, at amortized cost. Interest income on these instruments is recorded as "Other income" on the consolidated statements of operations and interest receivable is recognized as a separate asset and recorded in "Prepaid expenses and other current assets" on the consolidated balance sheets. The Company has not experienced a credit loss on the principal or interest receivable of its cash equivalents, short-term investments, or restricted investments. The Company pools its cash equivalents, short-term investments, and restricted investments by credit rating of the issuing financial institution and estimates an allowance for credit losses based on the corporate bond default ratios, evaluation of the impact of current and projected economic conditions, and probability of credit loss. Net credit loss expense for cash equivalents, short-term investments, and restricted investments was immaterial for the years ended December 31, 2025, 2024, and 2023. The Company does not measure an allowance for credit losses on interest receivable. Any uncollectible interest receivable is recognized by reversing interest income within the fiscal quarter that the interest becomes uncollectible.
In 2025, the Company started selling certain of its non-U.S. accounts receivable on a non-recourse basis to third-party financial institutions. These transactions are recognized as sales of receivables because effective control over, and risk related to, the receivables is transferred to the buyers. The Company derecognized $62,175 of accounts receivable as of December 31, 2025. The cash proceeds are presented as cash provided by operating activities in the consolidated statement of cash flows. After the sale of the accounts receivable, the Company collects payment from the customers and remits it to the third-party financial institutions.
Inventories
Inventories are stated at the lower of cost, determined by the moving average and first-in, first-out methods, or net realizable value. Inventories are adjusted for estimated obsolescence and written down to net realizable value based upon estimates of future demand, technology developments, and market conditions.
Property and Equipment
Property and equipment is carried at cost and is depreciated principally by the straight-line method based upon the estimated useful lives of the assets. Machinery and equipment are being depreciated over useful lives ofseven years toten years. Buildings and building improvements are being depreciated over useful lives oftwenty years toforty years. Construction in progress is not depreciated until the assets are placed in service. The estimated cost to complete construction in progress at December 31, 2025 was approximately $334,100. Depreciation expense was $211,542, $198,961, and $174,457 for the years ended December 31, 2025, 2024, and 2023, respectively. Gains and losses on the disposal of assets which do not qualify for presentation as discontinued operations are included in the determination of operating margin (within selling, general, and administrative expenses). Individually material gains and losses on disposal are separately disclosed in the notes to the consolidated financial statements.
Commitments and Contingencies
The Company has commitments for the purchase of assets to complete its construction in progress as disclosed above. The commitment period for most of these purchase commitments is less than one year.
Liabilities for loss contingencies, including environmental remediation costs, arising from claims, assessments, litigation, fines, penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment and/or remediation can be reasonably estimated. The costs for a specific environmental remediation site are discounted if the aggregate amount of the obligation and the amount and timing of the cash payments for that site are fixed or reliably determinable based upon information derived from the remediation plan for that site. Accrued liabilities for environmental matters recorded at December 31, 2025 and 2024 do not include claims against third parties.
Goodwill and Other Intangible Assets
Goodwill represents the excess of the cost of a business acquired over the fair value of the related net assets at the date of acquisition. Certain intangible assets may be assigned indefinite useful lives. Goodwill and indefinite-lived intangible assets are not amortized but rather are tested for impairment at least annually. The Company performs its annual goodwill impairment tests as of the first day of the fourth fiscal quarter. These tests are performed more frequently whenever events or changes in circumstances indicate that the assets might be impaired (see Note 19). The Company's business segments (see Note 15) represent its reporting units for goodwill impairment testing purposes. At December 31, 2025 and 2024, respectively, the Company hasno recorded indefinite-lived intangible assets.
Definite-lived intangible assets are amortized over their estimated useful lives. Patents and acquired technology are being amortized over useful lives ofseven years totwenty-five years. Capitalized software is amortized over periods ofthree years toten years, primarily included in "Costs of products sold" on the consolidated statements of operations. Customer relationships are amortized over useful lives offive years totwenty years. Noncompete agreements are amortized over periods ofthree years toten years. The Company continually evaluates the reasonableness of the useful lives of these assets.
GAAP prescribes a quantitative method for determining goodwill impairment. The Company has the option of performing a qualitative assessment before performing the quantitative impairment test. If it is determined, on the basis of qualitative factors, that the fair value of the reporting unit is not more likely than not less than the carrying amount, the quantitative impairment test is not required. If it is determined that the fair value of the reporting unit is more likely than not less than the carrying amount, the quantitative impairment test is required.
The Company determines the fair value of the reporting unit and compares that fair value to the net book value of the reporting unit. The fair value of the reporting unit is determined using various valuation techniques, including a comparable companies market multiple approach and a discounted cash flow analysis (an income approach). If the net book value of the reporting unit were to exceed the fair value, the Company would recognize an impairment charge.
Impairment of Long-Lived Assets
The carrying value of long-lived assets held-and-used, other than goodwill and indefinite-lived intangible assets, is evaluated when events or changes in circumstances indicate the carrying value may not be recoverable or the useful life has changed. The carrying value of a long-lived asset group is considered impaired when the total projected undiscounted cash flows from such asset group are separately identifiable and are less than the carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair market value of the long-lived asset group. Fair market value is determined primarily using present value techniques based on projected cash flows from the asset group. Losses on long-lived assets held-for-sale, other than goodwill and indefinite-lived intangible assets, are determined in a similar manner, except that fair market values are reduced for anticipated disposal costs.
Available-for-Sale Securities
Short-term investments and other assets reported on the accompanying consolidated balance sheets include time deposits with financial institutions whose original maturity exceeds three months, but less than one year that are classified as held-to-maturity instruments, and investments in marketable securities that are classified as available-for-sale instruments. The available-for-sale instruments include assets that are held in trust related to the Company’s non-qualified pension and deferred compensation plans (see Note 11) and assets that are intended to fund a portion of the Company’s other postretirement benefit obligations outside of the U.S. These assets are reported at fair value, based on quoted market prices as of the end of the reporting period. Unrealized gains and losses are reported as "Other income (expense)" on the consolidated statements of operations. At the time of sale, the assets that are held in trust related to the Company’s non-qualified pension and deferred compensation plans, any gains (losses) calculated by the specific identification method are recognized as a reduction (increase) to benefits expense, within "Selling, general, and administrative expenses" on the consolidated statements of operations.
Financial Instruments
The Company uses financial instruments in the normal course of its business, including from time to time, derivative financial instruments. Additionally, from time to time, the Company enters into contracts that are not considered derivative financial instruments in their entirety, but that include embedded derivative features.
Other financial instruments include cash and cash equivalents, held-to-maturity short-term investments, accounts receivable, and notes payable. The carrying amounts of these financial instruments reported on the accompanying consolidated balance sheets approximate their fair values due to the short-term nature of these assets and liabilities.
The fair value measurement accounting guidance establishes a valuation hierarchy of the inputs used to measure fair value. This hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:
Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.
Level 3: Unobservable inputs that reflect the Company’s own assumptions.
An asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.
Stock-Based Compensation
Compensation costs related to stock-based payment transactions are recognized in the consolidated financial statements. The amount of compensation cost is measured based on the grant-date fair value of the equity (or liability) instruments issued. The Company determines compensation cost for restricted stock units ("RSUs") and phantom stock units based on the grant-date fair value of the underlying common stock adjusted for expected dividends paid over the required vesting period for non-participating awards. Compensation cost is recognized over the period that an officer, employee, or non-employee director is required to provide service in exchange for the award. For RSUs with market conditions, the Company estimates the grant date fair value using a Monte Carlo valuation model and recognizes the expense for the awards over the period in which the condition is assessed regardless of whether the market condition is ultimately achieved. For awards subject to graded vesting, the Company recognizes expense over the service period for each separately vesting portion of the award as if the award was, in-substance, multiple awards. The Company recognizes compensation cost for RSUs that are expected to vest and records cumulative adjustments in the period that the expectation changes.
Foreign Currency Translation
The Company has significant operations outside of the United States. The Company finances most of its operations in Europe and certain locations in Asia in local currencies, and accordingly, these subsidiaries utilize the local currency as their functional currency. The Company’s operations in Israel, the United Kingdom, and most significant locations in Asia are largely financed in U.S. dollars, and accordingly, these subsidiaries utilize the U.S. dollar as their functional currency.
For those subsidiaries where the local currency is the functional currency, assets and liabilities on the accompanying consolidated balance sheets have been translated at the rate of exchange as of the balance sheet date. Translation adjustments do not impact the consolidated results of operations and are reported as a separate component of stockholders’ equity. Revenues and expenses are translated at the average exchange rate for the year. While the translation of revenues and expenses into U.S. dollars does not directly impact the statement of operations, the translation effectively increases or decreases the U.S. dollar equivalent of revenues generated and expenses incurred in those foreign currencies.
For those foreign subsidiaries where the U.S. dollar is the functional currency, all foreign currency financial statement amounts are remeasured into U.S. dollars. Exchange gains and losses arising from remeasurement of foreign currency-denominated monetary assets and liabilities are included in the consolidated results of operations.
Treasury Stock
The Company records treasury stock at cost, inclusive of fees, commissions, excise taxes, and other expenses, when outstanding common shares are repurchased. The Company allocates the excess of par value paid to repurchase outstanding common shares to "Capital in excess of par value" when treasury stock is retired.
Self-Insurance Programs
The Company uses a combination of insurance and self-insurance mechanisms to provide for the potential liabilities for workers’ compensation, general liability, property damage, director and officers’ liability, and vehicle liability.
As part of its self-insurance program for certain risks, the Company created a wholly-owned captive insurance entity in 2007. At December 31, 2025, the captive insurance entity provides only property and general liability insurance, although it is licensed to also provide directors’ and officers’ insurance. The captive insurance entity hadno amounts accrued for outstanding claims at December 31, 2025 and 2024.
Certain investments held by the captive insurance entity are restricted primarily for the purpose of potential insurance claims. Such amounts are recorded in other noncurrent assets, and total $14,337 and $12,001 at December 31, 2025 and 2024, respectively, representing required statutory reserves of the captive insurance entity.
Leases
The Company leases buildings and machinery and equipment used for manufacturing and/or sales and administrative purposes. The Company is also party to various service, warehousing, and other agreements that it evaluates for potential embedded leases. Substantially all of the Company’s leases are structured and classified as operating leases.
The Company leases assets in each region in which it operates. The Company’s leases are generally denominated in the currency of the leased assets' location, which may not be the functional currency of the subsidiary lessee. Accordingly, the Company remeasures its lease liability and recognizes a transactional gain/loss for leases denominated in currencies other than the functional currency of the subsidiary lessee.
The Company recognizes right of use assets and lease liabilities for leases greater than twelve months in duration based on the contract consideration for lease components through the term of the lease and the applicable discount rate. Leases with a duration less than or equal to twelve months are considered short-term leases. The Company does not recognize right of use assets or lease liabilities for short-term leases and classifies the expense as short-term lease expense. Variable lease payments based on an index or rate are included in the right of use assets and lease liabilities based on the effective rates at lease commencement. Changes in the rates or indices do not impact the right of use asset or lease liability and are recognized as a component of lease expense in the consolidated statements of operations. Variable lease payments not based on an index or rate are not included in the initial right of use asset and lease liability and are recognized when incurred as a component of lease expense in the consolidated statements of operations.
The Company has elected to not separate contract consideration for lease and non-lease components for its building leases. In addition to the noncancellable period of a lease, the Company includes periods covered by extension options it is reasonably certain to exercise, termination options that it is reasonably certain not to exercise, and extension and termination options controlled by the lessor in its determination of the lease term. The Company uses the rate implicit in the contract whenever possible when determining the applicable discount rate. When the implicit rate is not used, the Company employs a portfolio approach based on the duration of the lease. The portfolio lease rates are calculated monthly.
No individual lease is considered significant and there are no leases that have not yet commenced that are considered significant.
See Note 4 for additional information.
Restructuring and Severance Costs
Restructuring and severance costs reflect charges resulting from cost reduction programs implemented by the Company. Restructuring and severance costs include exit costs, severance benefits pursuant to an on-going arrangement, voluntary termination compensation under a defined program, and any related pension curtailment and settlement charges.
The Company recognizes expense for one-time benefits only after management has committed to a plan, the plan is sufficiently detailed to provide the number, classification, and location of employees to be terminated as well as the expected completion date, the plan has been sufficiently communicated to employees such that they are able to determine the type and amount of benefits they will receive if terminated, and it is unlikely that the plan will be significantly changed or withdrawn. If an employee is not required to render service beyond a minimum retention period, the Company recognizes expense once the aforementioned criteria have been met. If an employee is required to render service beyond a minimum retention period, the Company recognizes expense over the period that the employee is required to render future service.
The Company recognizes expense for on-going benefit arrangements when the liability is reasonably estimable and considered probable. The Company recognizes expense for voluntary separation / early retirement when the employee delivers an irrevocable voluntary termination notice pursuant to a defined Company program. The Company recognizes other exit costs as incurred.
See Note 3 for additional information.
Recent Accounting Pronouncements
Accounting Guidance Recently Adopted
In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-09, Improvements to Income Tax Disclosures. The ASU requires entities to consistently categorize and provide greater disaggregation of information in the rate reconciliation and income taxes paid. The ASU is effective for the Company for annual periods beginning on or after January 1, 2025, with the ability to early adopt. The Company adopted the ASU effective January 1, 2025. The adoption of the ASU did not impact the Company's financial position, results of operations, or cash flows, but increased its income tax disclosures.
Recent Accounting Guidance Not Yet Adopted
In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses. The ASU requires entities to provide expanded disclosures about specific income statement expenses, primarily through enhanced disclosures about purchases of inventory, employee compensation, depreciation, and intangible asset amortization. The ASU is effective for the Company for annual periods beginning on or after January 1, 2027, and interim periods beginning after January 1, 2028, with the ability to early adopt. The adoption of the ASU will not impact the Company's financial position, results of operations, or cash flows, but will increase disclosures.
In July 2025, the FASB issued ASU No. 2025-05, Measurement of Credit Losses for Accounts Receivable and Contract Assets. The ASU allows entities to elect a practical expedient that assumes that current conditions as of the balance sheet date do not change the remaining life of the asset when developing reasonable and supportable forecasts as part of estimating expected credit losses. The Company adopted the ASU effective January 1, 2026. The adoption of the ASU will not impact the Company's financial position, results of operations, or cash flows.
In September 2025, the FASB issued ASU No. 2025-06, Targeted Improvements to the Accounting for Internal-Use Software. The ASU requires entities to capitalize software costs when management has authorized and committed to funding the software project and it is probable that the project will be completed and the software will be used to perform the function intended. The Company early adopted the ASU effective January 1, 2026. The adoption of the ASU is not expected to have a significant impact on the Company's financial position, results of operations, or cash flows.
Reclassifications
Certain prior year amounts have been reclassified to conform with current year presentation. Such reclassifications had no effect on reported net earnings attributable to Vishay stockholders, total assets, stockholders' equity, or cash flows.
Note 2 - Acquisition and Divestiture Activities
As part of its growth strategy, the Company seeks to expand through targeted acquisitions of other manufacturers of electronic components. These acquisition targets include businesses that have established positions in major markets, reputations for product quality and reliability, and product lines with which the Company has substantial marketing and technical expertise. It also includes certain businesses that possess technologies which the Company expects to further develop and commercialize.
Year ended December 31, 2024
Newport wafer fab
On March 5, 2024, the Company acquired Nexperia’s wafer fabrication facility and operations located in Newport, South Wales, U.K. for $177,457 in cash, net of cash acquired. The wafer fabrication facility is located on 28 acres and is an automotive-certified, 200mm semiconductor wafer fab with capacity to produce more than 30,000 wafers per month. The transaction included contingent payments of $15,000, held in escrow. Selling, general, and administrative expenses for the fiscal year ended December 31, 2025 include an $11,293 benefit recognized in the second fiscal quarter of 2025 upon the favorable resolution of a contingency.
The transaction was funded by Vishay with cash on-hand. To effect the transaction, Vishay acquired a 100% interest in the legal entity Neptune 6 Limited, and its wholly-owned operating subsidiary, Nexperia Newport Limited, which owns and operates the Newport facility. Neptune 6 Limited was renamed "Vishay UK Holdings Limited," and Nexperia Newport Limited was renamed "Vishay Newport Limited."
Based on an estimate of fair values, the Company allocated the purchase price of the acquisition as follows:
| Net working deficit (excluding cash and cash equivalents) | $(339) |
|---|---|
| Property and equipment | 148,109 |
| Customer relationships | 4,000 |
| Other, net | 1,315 |
| Deferred taxes, net | (7,869) |
| Total identified assets and liabilities | 145,216 |
| Purchase price, net of cash acquired | 177,457 |
| Goodwill | $32,241 |
The acquired assets and liabilities, including goodwill, are included in the MOSFETs segment. The weighted average useful lives for customer relationships is 3 years. The goodwill associated with this transaction is not deductible for income tax purposes. See Note 19 for information on goodwill impairment testing.
The Company recognized $2,984 of acquisition costs classified as a component of selling, general, and administrative expenses. These costs were recognized in the third and fourth fiscal quarters of 2023 and first fiscal quarter of 2024.
The results and operations of this acquisition have been included in the MOSFETs segment since March 5, 2024. The inclusion of this acquisition did not have material impact on the Company's consolidated results.
Ametherm, Inc.
On June 5, 2024, the Company acquired all of the outstanding equity interests of Ametherm, Inc., a Carson City, Nevada-based manufacturer of inrush current limiting solutions and power thermistors, for $31,478 in cash, net of cash acquired. Based on an estimate of fair values, the Company allocated $17,000 of the purchase price to definite-lived intangible assets. After allocating the purchase price to assets acquired and liabilities assumed based on an estimation of their fair values at the date of acquisition, the Company recorded goodwill of $11,685 related to this acquisition. The goodwill related to this acquisition is included in the Resistors reporting unit for goodwill impairment testing. The results and operations of this acquisition have been included in the Resistors segment since June 5, 2024.
Birkelbach Kondensatortechnik GmbH
On December 17, 2024 the Company acquired Birkelbach Kondensatortechnik GmbH and certain related assets ("Birkelbach") for $15,839, net of cash acquired. Based in Erndtebrueck, Germany, Birkelbach is a manufacturer of metalized technical films for capacitor dielectrics. Vishay was a major customer of Birkelbach, and the acquired business has been vertically integrated into Vishay's Capacitors segment. Based on an estimate of fair values, the Company allocated $7,168 of the purchase price to definite-lived intangible assets. After allocating the purchase price to assets acquired and liabilities assumed based on an estimation of the fair values at the date of acquisition, the Company recorded goodwill of $777 related to this acquisition. The goodwill related to this acquisition is included in the Capacitors reporting unit for goodwill impairment testing. The results and operations of this acquisition have been included in the Capacitors segment since December 17, 2024.
Note 3 – Restructuring and Related Activities
In September 2024, the Company announced the implementation of restructuring actions designed to optimize the Company’s manufacturing footprint and streamline business decision making.
The restructuring actions are being implemented in phases and include:
| ● | Selling, general, and administrative functions streamlined through the fourth fiscal quarter of 2025. |
|---|---|
| ● | The closure of three manufacturing facilities. A Diodes segment back-end facility in Shanghai, China is expected to be closed by the end of 2026 with production transfers completed in phases beginning in the fourth quarter of 2025. In addition, two small facilities in the Resistors segment in Fichtelberg, Germany and Milwaukee, Wisconsin, are expected to be closed in 2026. |
| ● | Various changes in manufacturing operations and production transfers. |
The following table summarizes the activity to date related to this program:
| Expense recorded in 2024 | $40,614 |
|---|---|
| Utilized | (8,734) |
| Foreign currency translation | (1,292) |
| Balance at December 31, 2024 | $30,588 |
| Utilized | (15,268) |
| Foreign currency translation | 2,106 |
| Balance at December 31, 2025 | $17,426 |
Severance payment terms vary by country, but generally are paid in a lump sum at cessation of employment. Some payments are made over an extended period. As of December 31, 2025, substantially all of the liability is current and is included in other accrued expenses in the accompanying consolidated balance sheet.
Note 4 – Leases
The net right of use assets and lease liabilities recognized on the consolidated balance sheets for the Company's operating leases as of December 31, 2025 and 2024 are presented below:
| December 31, 2025 | December 31, 2024 | |
|---|---|---|
| Right of use assets | ||
| Operating Leases | ||
| Buildings and improvements | $114,199 | $112,528 |
| Machinery and equipment | 5,547 | 5,425 |
| Total | $119,746 | $117,953 |
| Current lease liabilities | ||
| Operating Leases | ||
| Buildings and improvements | $23,555 | $22,993 |
| Machinery and equipment | 2,991 | 2,908 |
| Total | $26,546 | $25,901 |
| Long-term lease liabilities | ||
| Operating Leases | ||
| Buildings and improvements | $93,342 | $91,772 |
| Machinery and equipment | 2,457 | 2,446 |
| Total | $95,799 | $94,218 |
| Total lease liabilities | $122,345 | $120,119 |
Lease expense is classified in the statements of operations based on asset use. Total lease cost recognized on the consolidated statements of operations is as follows:
| Years ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Lease expense | |||
| Operating lease expense | $28,700 | $29,787 | $27,909 |
| Short-term lease expense | 2,086 | 964 | 988 |
| Variable lease expense | 595 | 581 | 566 |
| Total lease expense | $31,381 | $31,332 | $29,463 |
The Company paid $28,976, $29,744, and $28,164 for its operating leases during the years ended December 31, 2025, 2024, and 2023, respectively, which are included in operating cash flows on the consolidated statements of cash flows. The weighted-average remaining lease term for the Company's operating leases is 8.3 years and the weighted-average discount rate is 6.7% as of December 31, 2025.
The undiscounted future lease payments for the Company's operating lease liabilities are as follows:
| 2026 | $27,429 |
| 2027 | 24,534 |
| 2028 | 19,432 |
| 2029 | 16,390 |
| 2030 | 14,730 |
| Thereafter | 57,582 |
The undiscounted future lease payments presented in the table above include payments through the term of the lease, which may include periods beyond the noncancellable term. The difference between the total payments above and the lease liability balance is due to the discount rate used to calculate lease liabilities.
Note 5 – Income Taxes
Changes in Tax Laws and Regulations
United States
On July 4, 2025, H.R. 1 (the "Act"), a tax reconciliation act, was enacted into law in the United States. The Act did not change the U.S. federal tax rate and most of the provisions of the Act are effective for tax years beginning after December 31, 2025. The Company has recorded no change to the deferred U.S. taxes directly related to the Act. The Act allows the deduction in tax year 2025, or in tax years 2025 and 2026, of some previously capitalized research and development costs. The Company anticipates that these additional tax deductions may preclude the utilization of a U.S. foreign tax credit ("FTC") that is due to expire in 2028. As an indirect result of this change in tax law, the Company recorded a valuation allowance of $9,420 on the deferred tax asset related to this FTC.
On December 22, 2017, the Tax Cuts and Jobs Act (the "TCJA") was enacted in the United States. Under previous law, companies could indefinitely defer U.S. income taxation on unremitted foreign earnings. The TCJA imposed a one-time transition tax on deferred foreign earnings, payable in defined increments over eight years. Installments of $47,027 were paid in 2025, $37,622 were paid in 2024, $27,670 were paid in 2023, and $14,757 in each of 2022, 2021, 2020, 2019, and 2018. The 2025 installment was the last payment.
The Company has elected to account for Global Intangible Low-Taxed Income ("GILTI") tax in the period in which it is incurred and, therefore, does not provide any deferred taxes in the consolidated financial statements at December 31, 2025, 2024, or 2023.
Germany
In the third fiscal quarter of 2025, the Federal Republic of Germany enacted tax legislation decreasing the federal tax rate beginning in 2028 by 1% per year for five years. The Company recorded deferred tax expense of $4,237 to reduce the carrying amount of deferred tax assets in Germany based on these new rates.
Changes in Indefinite Reversal Assertion
The Company made the determination in 2021 that substantially all unremitted foreign earnings in Israel were no longer indefinitely reinvested. The Company made the determination in 2022 that substantially all unremitted earnings in Germany were no longer indefinitely reinvested.
These changes in this indefinite reinvestment assertions provide greater access to the Company's worldwide cash balances to fund its growth plan and its Stockholder Return Policy. While the change in assertion provides access to these balances, these amounts will be repatriated only as needed. The withholding taxes associated with any distribution to the United States is payable upon distribution. The Company repatriated $75,000 of accumulated earnings to the United States in the second fiscal quarter of 2025 and paid withholding taxes, in Israel, of $9,375. The Company repatriated $120,000 of accumulated earnings to the United States in the second fiscal quarter of 2024 and paid withholding taxes, in Israel, of $15,000. During the fourth fiscal quarter of 2023, the Company repatriated $325,000 of accumulated earnings to the United States and paid withholding taxes, in Germany and Israel, of $63,600.
At December 31, 2025, approximately $231,187 of German earnings and approximately $261,452 of Israeli earnings are deemed not indefinitely reinvested. The aggregate tax liability recorded for unremitted earnings at December 31, 2025 is approximately $76,000, which includes amounts accrued subsequent to the changes in indefinite reinvestment determinations described above.
There are amounts of unremitted foreign earnings in countries other than Israel and Germany, which continue to be reinvested indefinitely, and the Company has made no provision for incremental foreign income taxes and withholding taxes payable to foreign jurisdictions related to these amounts. Determination of the amount of the unrecognized deferred foreign tax liability for these amounts is not practicable because of the complexities associated with its hypothetical calculation.
Income before taxes consists of the following components:
| Years ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Domestic | $(172,986) | $(172,519) | $67,938 |
| Foreign | 198,499 | 170,130 | 399,464 |
| $25,513 | $(2,389) | $467,402 | |
Significant components of income taxes are as follows:
| Years ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Current: | |||
| Federal | $456 | $1,936 | $14,594 |
| State and local | 153 | 407 | 1,769 |
| Foreign | 54,121 | 63,537 | 152,343 |
| 54,730 | 65,880 | 168,706 | |
| Deferred: | |||
| Federal | (24,586) | (24,492) | (4,871) |
| State and local | (1,347) | (788) | (3,651) |
| Foreign | 5,694 | (13,234) | (18,295) |
| (20,239) | (38,514) | (26,817) | |
| Total income tax expense | $34,491 | $27,366 | $141,889 |
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities are as follows:
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Deferred tax assets: | ||
| Pension and other retiree obligations | $24,172 | $27,779 |
| Inventories | 28,453 | 26,004 |
| Net operating loss carryforwards | 72,349 | 74,244 |
| Tax credit carryforwards | 80,081 | 67,192 |
| Research and development costs | 34,307 | 25,582 |
| Interest | 31,135 | 23,886 |
| Other accruals and reserves | 34,869 | 36,232 |
| Total gross deferred tax assets | 305,366 | 280,919 |
| Less valuation allowance | (92,117) | (92,876) |
| 213,249 | 188,043 | |
| Deferred tax liabilities: | ||
| Property and equipment | (19,131) | (20,032) |
| Tax deductible goodwill | (8,770) | (7,889) |
| Intangibles other than goodwill | (7,526) | (8,937) |
| Earnings not indefinitely reinvested | (80,203) | (78,977) |
| Other - net | (11,421) | (8,802) |
| Total gross deferred tax liabilities | (127,051) | (124,637) |
| Net deferred tax assets | $86,198 | $63,406 |
The Company makes significant judgments regarding the realizability of its deferred tax assets (principally net operating losses and tax credits). The carrying value of deferred tax assets is based on the Company’s assessment that it is more likely than not that the Company will realize these assets after consideration of all available positive and negative evidence.
A reconciliation of income tax expense at the U.S. federal statutory income tax rate to actual income tax provision for the year ended December 31, 2025 is as follows:
| Year Ended | ||
|---|---|---|
| U.S. federal statutory income tax | $5,358 | 21.0% |
| State and local income taxes, net of federal benefit* | (939) | (3.7)% |
| Foreign tax effects: | ||
| China: | ||
| Withholding on dividends | 6,658 | 26.1% |
| Other | 1,813 | 7.1% |
| Germany: | ||
| Effects of changes in tax laws | 4,237 | 16.6% |
| Other | 1,048 | 4.1% |
| Israel: | ||
| Incentives | (3,230) | (12.7)% |
| Withholding on dividends | 6,860 | 26.9% |
| Other | 812 | 3.2% |
| Other foreign jurisdictions | (1,028) | (4.0)% |
| Effects of cross-border tax laws: | ||
| Subpart F | 4,380 | 17.2% |
| GILTI | 3,580 | 14.0% |
| Other | 2,531 | 9.9% |
| Tax credits | ||
| U.S. foreign tax credit | (6,663) | (26.1)% |
| Changes in valuation allowances | 9,420 | 36.9% |
| Nontaxable or nondeductible items: | ||
| Executive compensation | 2,666 | 10.5% |
| Other | (610) | (2.4)% |
| Changes in uncertain tax benefits | (185) | (0.7)% |
| Other adjustments | (2,217) | (8.7)% |
| Total tax expense | $34,491 | 135.2% |
- State taxes in Minnesota, Arizona, and Illinois made up the majority (greater than 50%) of the tax effect in this category.
A reconciliation of income tax expense at the U.S. federal statutory income tax rate to actual income tax provision for the years ended December 31, 2024 and 2023 is as follows:
| Years ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Tax at statutory rate | $(502) | $98,154 |
| State income taxes, net of U.S. federal tax benefit | (301) | (1,487) |
| Effect of foreign operations | (962) | 9,260 |
| Impairment of goodwill | 13,962 | - |
| Tax on earnings not indefinitely reinvested | 9,016 | 37,061 |
| Change in valuation allowance on deferred tax assets | - | (1,770) |
| Foreign income taxable in the U.S. | 16,571 | 11,829 |
| Foreign tax credit | (11,506) | (29,997) |
| U.S. Base Erosion Anti-Abuse Tax | 1,063 | 16,837 |
| Other | 25 | 2,002 |
| Total income tax expense | $27,366 | $141,889 |
Vishay operates in a global environment with significant operations in various locations outside the United States. Accordingly, the consolidated income tax rate is a composite rate reflecting our earnings and the applicable tax rates in the various locations where we operate. Part of Vishay's historical strategy has been to achieve cost savings through the transfer and expansion of manufacturing operations to countries where it can take advantage of lower labor costs. With the reduction in the U.S. statutory rate to 21% beginning January 1, 2018, Vishay expects that its effective tax rate will be higher than the U.S. statutory rate, excluding unusual transactions.
Income tax expense for the year ended December 31, 2025 includes certain discrete tax items for changes in uncertain tax positions, valuation allowances, tax rates, and other related items. These items totaled $13,657 in 2025. There were no unusual tax items for the years ended December 31, 2024 and 2023.
At December 31, 2025, the Company had the following significant net operating loss carryforwards for tax purposes:
| Expires | |||
|---|---|---|---|
| Belgium | $117,171 | No expiration | |
| Israel | 3,575 | No expiration | |
| Italy | 18,169 | No expiration | |
| Netherlands | 10,334 | No expiration | |
| The Republic of China (Taiwan) | 5,546 | 2027 - 2028 | |
| United Kingdom | 71,883 | No expiration | |
| U.S. Federal | 34,206 | No expiration | |
| California | 17,184 | 2028 - 2045 | |
| Pennsylvania | 436,026 | 2027 - 2045 | |
| Arizona | 19,570 | 2032 - 2045 | |
At December 31, 2025, the Company had the following significant tax credit carryforwards available:
| Expires | |||
|---|---|---|---|
| U.S. Foreign Tax Credit | $50,592 | 2028 - 2035 | |
| U.S. Research and Development Credit | 5,109 | 2038 - 2045 | |
| California Research Credit | 24,380 | No expiration | |
The following table summarizes income taxes paid by jurisdiction for the year ended December 31, 2025:
| Year Ended | |
|---|---|
| U.S. Federal | $47,895 |
| U.S. State and Local | (99) |
| China | 12,424 |
| Israel | 14,950 |
| The Republic of China (Taiwan) | 9,427 |
| Other Foreign | 16,175 |
| Total income taxes paid | $100,772 |
Net income taxes paid were $136,784, and $224,232 for the years ended December 31, 2024, and 2023, respectively. Net income taxes paid for the years ended December 31, 2025, 2024, and 2023, respectively, include withholding taxes for repatriation activity. Net income taxes paid for the years ended December 31, 2025, 2024, and 2023 also includes $47,027, $37,622, and $27,670, respectively, of TCJA transition tax paid.
The following table summarizes changes in the liabilities associated with unrecognized tax benefits:
| Years ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Balance at beginning of year | $32,500 | $12,857 | $18,429 |
| Addition based on tax positions related to the current year | 2,416 | 922 | 1,210 |
| Addition based on tax positions related to prior years | 3,967 | 19,905 | 5,455 |
| Currency translation adjustments | 815 | (185) | 230 |
| Reduction based on tax positions related to prior years | (1,237) | - | - |
| Reduction for settlements | (4,446) | - | (10,000) |
| Reduction for lapses of statute of limitation | (1,012) | (999) | (2,467) |
| Balance at end of year | $33,003 | $32,500 | $12,857 |
In 2024, the Company recorded a deferred tax asset and offsetting liability for unrecognized tax benefits related to an acquired net operating loss carryover.
All of the unrecognized tax benefits of $33,003 and $32,500, as of December 31, 2025 and 2024, respectively, would reduce the effective tax rate if recognized.
The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense. At December 31, 2025 and 2024, the Company had accrued interest and penalties related to the unrecognized tax benefits of $1,422 and $1,564, respectively. During the years ended December 31, 2025, 2024, and 2023, the Company recognized $360, $303, and $821, respectively, in interest and penalties.
The Company and its subsidiaries file U.S. federal income tax returns, as well as tax returns in multiple states and foreign jurisdictions. During the years ended December 31, 2025, 2024, and 2023, certain tax examinations were concluded and certain statutes of limitations lapsed. The tax provision for those years includes adjustments related to the resolution of these matters, as reflected in the table above. During 2023, the Company settled an examination of its U.S. federal income tax returns for the years ended December 31, 2017 through 2019. The federal income tax returns for the years 2022 through 2024 remain subject to examination. The tax returns of significant non-U.S. subsidiaries currently under examination are located in the following jurisdictions: Israel (2021), China (2022 through 2024), India (2004 through 2023), and Philippines (2020 through 2022). The Company and its subsidiaries also file income tax returns in other taxing jurisdictions in the U.S. and around the world, many of which are still open to examination.
The timing of the resolution of income tax examinations is highly uncertain, as are the amounts and timing of tax payments that result from such examinations. These events could cause large fluctuations in the balance sheet classification of current and non-current unrecognized tax benefits.
Note 6 – Long-Term Debt
Long-term debt consists of the following:
| December 31, 2025 | December 31, 2024 | |
|---|---|---|
| Credit Facility | $219,000 | $136,000 |
| Convertible senior notes, due 2025 | - | 41,911 |
| Convertible senior notes, due 2030 | 750,000 | 750,000 |
| Deferred financing costs | (18,107) | (22,892) |
| 950,893 | 905,019 | |
| Less current portion | - | - |
| $950,893 | $905,019 |
Credit Facility
The Company maintains a credit agreement with a consortium of banks led by JPMorgan Chase Bank, N.A., as administrative agent, and the lenders (the "Credit Facility"). In May 2023, the Company entered into an Amendment and Restatement Agreement, which provides an aggregate commitment of $750,000 of revolving loans available until May 8, 2028. The Credit Facility also provides for the ability of Vishay to request up to $300,000 of incremental facilities, subject to the satisfaction of certain conditions, which could take the form of additional revolving commitments, incremental “term loan A” or “term loan B” facilities, or incremental equivalent debt.
U.S. Dollar borrowings under the Credit Facility bear interest at Secured Overnight Financing Rate ("SOFR") plus a credit spread and an interest margin. The Credit Facility also allows for borrowings in euro, British sterling, and Japanese yen, subject to a $300,000 limit. Borrowings in foreign currency bear interest at a local reference rate plus an interest margin. The applicable interest margin is based on the Company's total leverage ratio. Based on the Company's current total leverage ratio, borrowings bear interest at SOFR plus 2.10%, including the applicable credit spread. The Company also pays a commitment fee, also based on its total leverage ratio, on undrawn amounts. The undrawn commitment fee, based on the Company's total current leverage ratio, is 0.35% per annum.
The Credit Facility requires the maintenance of financial covenant ratios. For compliance purposes, pursuant to the Credit Facility, the leverage ratio is computed on a net basis, reducing the measure of outstanding debt by up to $250,000 of unrestricted cash. The Interest Coverage Ratio is computed excluding capital expenditures. The Company must maintain a net leverage ratio of at least 3.25 to 1.00 and a minimum Interest Coverage Ratio of 3.25 to 1.00.
Borrowings under the Credit Facility are secured by a lien on substantially all assets, including accounts receivable, inventory, machinery and equipment, and general intangibles (but excluding real estate, intellectual property registered or licensed solely for use in, or arising solely under the laws of, any country other than the United States, assets located solely outside of the United States and deposit and securities accounts), of the Company and certain significant subsidiaries located in the United States, and pledges of stock in certain significant domestic and foreign subsidiaries; and are guaranteed by certain significant subsidiaries.
The Credit Facility limits or restricts the Company and its subsidiaries, from, among other things, incurring indebtedness, incurring liens on its respective assets, making investments and acquisitions (assuming the Company’s pro forma net leverage ratio is greater than 2.75 to 1.00), making asset sales, and paying cash dividends and making other restricted payments (assuming the Company's pro forma net leverage ratio is greater than 2.50 to 1.00), and requires the Company to comply with other covenants.
The Credit Facility also contains customary events of default, including, but not limited to, failure to pay principal or interest, failure to pay or default under other material debt, material misrepresentation or breach of warranty, violation of certain covenants, a change of control, the commencement of bankruptcy proceedings, the insolvency of the Company or certain of its significant subsidiaries, and the rendering of a judgment in excess of $50,000 against the Company or its subsidiaries. Upon the occurrence of an event of default under the Credit Facility, the Company's obligations under the credit facility may be accelerated and the lending commitments under the credit facility may be terminated.
At December 31, 2025 there was $253,984 accessible under the Credit Facility at the current EBITDA level. At December 31, 2024, there was $467,245 available under the Credit Facility. Letters of credit totaling $11,988 and $2,062 were outstanding at December 31, 2025 and 2024, respectively.
Note 6 – Long-Term Debt (continued)
Convertible Debt Instruments
The following table summarizes some key facts and terms regarding the outstanding convertible senior notes due 2030 as of December 31, 2025:
| Issuance date | September 12, 2023 |
|---|---|
| Maturity date | September 15, 2030 |
| Principal amount | $750,000 |
| Cash coupon rate (per annum) | 2.25% |
| Conversion rate effective December 3, 2025 (per $1 principal amount) | 33.1609 |
| Effective conversion price (per share) | $30.16 |
| 130% of the conversion price (per share) | $39.21 |
Convertible Senior Notes due 2030
In September 2023, the Company issued $750,000 aggregate principal amount of 2.25% convertible senior notes due 2030 (the “2030 Notes”) to qualified institutional buyers pursuant to an exemption from registration provided by Rule 144A under the Securities Act. The Company used the net proceeds from this offering to repurchase $370,242 principal amount of its outstanding 2.25% convertible senior notes due 2025 (the “2025 Notes”) (as further described below), to reduce the outstanding balance of its Credit Facility, to enter into capped call transactions (as further described below), and for other general corporate purposes.
The 2030 Notes bear interest at a rate of 2.25% per year payable semi-annually in arrears on March 15 and September 15 of each year, beginning March 15, 2024. The 2030 Notes mature on September 15, 2030, unless earlier repurchased or converted.
The 2030 Notes are convertible into shares of Vishay common stock at an initial conversion rate of 33.1609 shares of common stock per $1 principal amount of the notes, subject to adjustment. This initial conversion price represents a premium of 20% to the closing price of Vishay's common stock on September 7, 2023, which was $25.13 per share. This represents an initial effective conversion price of approximately $30.16 per share. The conversion rate of the 2030 Notes is not adjusted for quarterly cash dividends equal to or less than $0.10 per share of common stock. Pursuant to the indenture governing the 2030 Notes, the Company is required to satisfy its conversion obligations by paying cash equal to the principal amount of notes and settle any additional value in cash and/or shares at its discretion. Vishay must provide additional shares upon conversion if there is a "fundamental change" in the business as defined in the indenture governing the notes.
The Company may not redeem the 2030 Notes prior to September 20, 2027. The Company may redeem for cash all or part of the 2030 Notes, at its option, on or after September 20, 2027, if the sale price of Vishay’s common stock has been at least 130% of the conversion price for a specified period at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest. If the Company elects to redeem fewer than all of the outstanding 2030 Notes, at least $100,000 aggregate principal amount of 2030 Notes must be outstanding and not subject to redemption.
Prior to March 15, 2030, the holders of the 2030 Notes may convert their notes only under the following conditions: (1) the sale price of Vishay common stock reaches 130% of the applicable conversion price for a specified period; (2) the trading price of the notes falls below 98% of the product of the last reported sale price of Vishay’s common stock and the conversion rate for a specified period; (3) the Company calls any or all of the 2030 Notes for redemption; or (4) upon the occurrence of specified corporate transactions.
Capped Call Transactions
In September 2023, in connection with the pricing and initial purchasers’ exercise in full of their option to purchase additional 2030 Notes, the Company entered into separate base and additional privately negotiated capped call transactions with an affiliate of an initial purchaser and certain other financial institutions. The capped call will initially cover, subject to customary anti-dilution adjustments, the aggregate number of shares of the Company’s common stock that initially underlie the 2030 Notes. The Company used $94,200 of the net proceeds from the 2030 Notes to pay the cost of the capped call transactions. The cap price of the capped call will initially be $43.98 per share, which represents a premium of approximately 75% over the last reported sale price of the Company’s common stock on September 7, 2023, and is subject to certain adjustments under the terms of the capped call.
The capped call transactions are separate transactions entered into by the Company with each of the capped call counterparties, are not part of the terms of the 2030 Notes, and do not affect any holder’s rights under the 2030 Notes. Holders of the 2030 Notes do not have any rights with respect to the capped call. The capped call is classified within stockholders’ equity on the consolidated balance sheet.
Note 6 – Long-Term Debt (continued)
Convertible Senior Notes due 2025
The Company used $386,745 of the net proceeds from the 2023 offering of the 2030 Notes to repurchase $370,242 principal amount of its outstanding 2025 Notes. As a result, the Company recognized a loss on early extinguishment of the 2025 Notes of $18,874, including the write-off of a portion of unamortized debt issuance costs. The Company repurchased $53,191 principal amount of its remaining outstanding 2025 Notes in 2024. The gain on early extinguishment was not material.
The convertible senior notes due 2025 matured on June 15, 2025. Upon maturity, $41,911 aggregate principal amount of the convertible senior notes due 2025 were settled in cash, funded by borrowings on the revolving credit facility. No shares were issued to settle the convertible senior notes due 2025.
Other Borrowings Information
The Credit Facility, of which $219,000 was drawn as of December 31, 2025, expires in 2028. The convertible senior notes mature in 2030.
At December 31, 2025 and 2024, the Company had committed and uncommitted credit lines with various foreign banks aggregating approximately $61,000 and $32,000, respectively, with substantially no amounts borrowed.
Interest paid was $33,812, $21,732, and $17,242 for the years ended December 31, 2025, 2024, and 2023, respectively. Deferred financing costs are recognized as non-cash interest expense. Non-cash interest expense was $4,808, $4,957, and $3,735 for the years ended December 31, 2025, 2024, and 2023, respectively.
See Note 18 for further discussion on the fair value of the Company’s long-term debt.
Note 7 – Stockholders’ Equity
The Company’s Class B common stock carries 10 votes per share while the common stock carries 1 vote per share. Class B shares are transferable only to certain permitted transferees while the common stock is freely transferable. Class B shares are convertible on aone-for-one basis at any time into shares of common stock. Transfers of Class B shares other than to permitted transferees result in the automatic conversion of the Class B shares into common stock.
The Board of Directors may only declare dividends or other distributions with respect to the common stock or the Class B common stock if it grants such dividends or distributions in the same amount per share with respect to the other class of stock. Stock dividends or distributions on any class of stock are payable only in shares of stock of that class. Shares of either common stock or Class B common stock cannot be split, divided, or combined unless the other is also split, divided, or combined equally. Cash dividends were paid quarterly in 2025 and 2024.
The Credit Facility also allows an unlimited amount of defined "Restricted Payments," which include cash dividends and share repurchases, provided the Company's pro forma net leverage ratio is equal to or less than 2.50 to 1.00. If the Company's pro forma net leverage ratio is greater than 2.50 to 1.00, the Credit Facility allows such payments up to $100,000 per annum (subject to a cap of $300,000 for the term of the facility, with up to $25,000 of any unused amount of the $100,000 per annum base available for use in the next succeeding calendar year).
At December 31, 2025, the Company had reserved shares of common stock for future issuance as follows:
| Restricted stock units outstanding, assuming performance-based awards at maximum | 4,613,000 |
|---|---|
| Phantom stock units outstanding | 136,000 |
| 2023 Long-Term Incentive Plan - available to grant | 1,524,000 |
| Convertible senior notes, due 2030 | 24,870,675 |
| Conversion of Class B common stock | 12,097,148 |
| Total | 43,240,823 |
In 2022, the Company's Board of Directors adopted a Stockholder Return Policy that will remain in effect until such time as the Board votes to amend or rescind the policy. The Stockholder Return Policy calls for the Company to return a prescribed amount of cash flows on an annual basis. The Company intends to return such amounts directly, in the form of dividends, or indirectly, in the form of stock repurchases.
The following table summarizes activity pursuant to this policy:
| Years ended December 31, | ||||
|---|---|---|---|---|
| 2025 · 2024 | ||||
| Dividends paid to stockholders | $ | 54,238 | $ | 54,672 |
| Stock repurchases | 12,528 | 50,406 | ||
| Total | $ | 66,766 | $ | 105,078 |
The number of shares of common stock being held as treasury stock was 9,933,595 as of December 31, 2024. During the fourth fiscal quarter of 2025, the Company retired 10,662,155 shares of common stock held as treasury stock at a cost of $224,590. There wereno shares of common stock held as treasury stock as of December 31, 2025.
Note 8 – Details of Expenses
The caption “Other” on the accompanying consolidated statements of operations consists of the following:
| Years ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Foreign exchange gain (loss) | $(895) | $774 | $677 |
| Interest income | 13,363 | 25,479 | 31,353 |
| Other components of periodic pension expense | (7,771) | (7,899) | (8,730) |
| Investment income (expense) | 796 | (519) | 1,347 |
| Other | 1,803 | 1,629 | 616 |
| $7,296 | $19,464 | $25,263 | |
Note 9 – Other Accrued Expenses
Other accrued expenses consist of the following:
| December 31, | ||||
|---|---|---|---|---|
| 2025 · 2024 | ||||
| Sales returns and allowances | $ | 41,249 | $ | 43,445 |
| Goods received, not yet invoiced | 67,599 | 40,577 | ||
| Accrued VAT taxes payable | 56,113 | 43,861 | ||
| Other | 135,070 | 136,588 | ||
| $ | 300,031 | $ | 264,471 | |
Sales returns and allowances accrual activity is shown below:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Beginning balance | $43,445 | $47,760 | $46,979 |
| Sales returns and allowances | 89,500 | 88,775 | 101,696 |
| Credits issued | (92,876) | (92,438) | (101,324) |
| Foreign currency | 1,180 | (652) | 409 |
| Ending balance | $41,249 | $43,445 | $47,760 |
Note 10 – Accumulated Other Comprehensive Income (Loss)
The cumulative balance of each component of other comprehensive income (loss) and the income tax effects allocated to each component are as follows:
| Pension and other post- retirement actuarial items | Currency translation adjustment | Total | |
|---|---|---|---|
| Balance at January 1, 2023 | $(7,598) | $(3,229) | $(10,827) |
| Other comprehensive income before reclassifications | (10,338) | 28,165 | $17,827 |
| Tax effect | 2,462 | - | $2,462 |
| Other comprehensive income before reclassifications, net of tax | (7,876) | 28,165 | $20,289 |
| Amounts reclassified out of AOCI | 1,181 | - | $1,181 |
| Tax effect | (306) | - | $(306) |
| Amounts reclassified out of AOCI, net of tax | 875 | - | $875 |
| Net comprehensive income (loss) | $(7,001) | $28,165 | $21,164 |
| Balance at December 31, 2023 | $(14,599) | $24,936 | $10,337 |
| Other comprehensive income before reclassifications | 4,062 | (49,272) | $(45,210) |
| Tax effect | (1,794) | - | $(1,794) |
| Other comprehensive income before reclassifications, net of tax | 2,268 | (49,272) | $(47,004) |
| Amounts reclassified out of AOCI | 1,568 | - | $1,568 |
| Tax effect | (193) | - | $(193) |
| Amounts reclassified out of AOCI, net of tax | 1,375 | - | $1,375 |
| Net comprehensive income (loss) | $3,643 | $(49,272) | $(45,629) |
| Balance at December 31, 2024 | $(10,956) | $(24,336) | $(35,292) |
| Other comprehensive income before reclassifications | 10,189 | 107,867 | $118,056 |
| Tax effect | (2,763) | - | $(2,763) |
| Other comprehensive income before reclassifications, net of tax | 7,426 | 107,867 | $115,293 |
| Amounts reclassified out of AOCI | 1,645 | - | $1,645 |
| Tax effect | (252) | - | $(252) |
| Amounts reclassified out of AOCI, net of tax | 1,393 | - | $1,393 |
| Net comprehensive income (loss) | $8,819 | $107,867 | $116,686 |
| Balance at December 31, 2025 | $(2,137) | $83,531 | $81,394 |
Other comprehensive income (loss) includes Vishay's proportionate share of other comprehensive income (loss) of nonconsolidated subsidiaries accounted for under the equity method.
Note 11 – Pensions and Other Postretirement Benefits
The Company maintains various retirement benefit plans. GAAP requires employers to recognize the funded status of a benefit plan, measured as the difference between plan assets at fair value and the benefit obligation, in its balance sheet. The recognition of the funded status on the balance sheet requires employers to recognize actuarial items (such as actuarial gains and losses, prior service costs, and transition obligations) as a component of other comprehensive income, net of tax.
The following table summarizes amounts recorded on the accompanying consolidated balance sheets associated with these various retirement benefit plans:
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Included in "Other assets": | ||
| Non-U.S. pension plans | $2,507 | $1,216 |
| Total included in other assets | $2,507 | $1,216 |
| Included in "Payroll and related expenses": | ||
| U.S. pension plans | $(132) | $(880) |
| Non-U.S. pension plans | (7,970) | (6,720) |
| U.S. other postretirement plans | (221) | (520) |
| Non-U.S. other postretirement plans | (1,027) | (799) |
| Total included in payroll and related expenses | $(9,350) | $(8,919) |
| Accrued pension and other postretirement costs: | ||
| U.S. pension plans | $(27,593) | $(27,758) |
| Non-U.S. pension plans | (126,130) | (125,719) |
| U.S. other postretirement plans | (1,844) | (3,418) |
| Non-U.S. other postretirement plans | (6,129) | (6,287) |
| Other retirement obligations | (11,027) | (10,518) |
| Total accrued pension and other postretirement costs | $(172,723) | $(173,700) |
| Accumulated other comprehensive loss: | ||
| U.S. pension plans | $574 | $11 |
| Non-U.S. pension plans | 8,177 | 18,861 |
| U.S. other postretirement plans | (2,675) | (1,329) |
| Non-U.S. other postretirement plans | 788 | 1,158 |
| Total accumulated other comprehensive loss* | $6,864 | $18,701 |
- -Amounts included in accumulated other comprehensive loss are presented in this table pre-tax
Defined Benefit Pension Plans
U.S. Pension Plans
The Company maintained several defined benefit pension plans which covered most full-time U.S. employees. These included pension plans which are “qualified” under the Employee Retirement Income Security Act of 1974 (“ERISA”) and the Internal Revenue Code, and “non-qualified” pension plans which provide defined benefits primarily to U.S. employees whose benefits under the qualified pension plan would be limited by ERISA and the Internal Revenue Code. The Company’s principal qualified U.S. pension plan (the Vishay Retirement Plan) was frozen effective January 1, 2009 and terminated in 2016.
The Company’s principal non-qualified U.S. pension plan (the Vishay Non-qualified Retirement Plan) was a contributory pension plan designed to provide similar defined benefits to covered U.S. employees whose benefits under the Vishay Retirement Plan were limited by the Internal Revenue Code. The Vishay Non-qualified Retirement Plan was similar in construction to the Vishay Retirement Plan, except that the plan is not qualified under the Internal Revenue Code.
The Vishay Non-qualified Retirement Plan, like all non-qualified plans, is considered to be unfunded. The Company maintains a non-qualified trust, referred to as a “rabbi” trust, to fund benefit payments under this plan. Rabbi trust assets are subject to creditor claims under certain conditions and are not the property of employees. Therefore, they are accounted for as other noncurrent assets. Assets held in trust related to the non-qualified pension plan were $20,067 and $19,842 at December 31, 2025 and 2024, respectively.
In 2008, the Company adopted amendments to the Vishay Non-Qualified Retirement Plan such that effective January 1, 2009, the plan was frozen. Pursuant to these amendments, no new employees may participate in the plans, no further participant contributions were required or permitted, and no further benefits shall accrue after December 31, 2008. Benefits accumulated as of December 31, 2008 will be paid to employees upon or following retirement, and the Company will likely need to make additional cash contributions to the rabbi trust to fund this accumulated benefit obligation.
The Company also maintains other pension plans which provide supplemental defined benefits primarily to former U.S. employees whose benefits under qualified pension plans were limited by the Internal Revenue Code. These non-qualified plans are all non-contributory plans, and are considered to be unfunded.
In 2004, the Company entered into an employment agreement with Dr. Felix Zandman, its former Executive Chairman and then-Chief Executive Officer. Pursuant to this agreement, the Company is providing an annual retirement benefit of approximately $614 to his surviving spouse. The Company maintains a non-qualified trust, referred to as a “rabbi” trust, to fund benefit payments under this plan. Rabbi trust assets are subject to creditor claims under certain conditions and are not the property of employees. Therefore, they are accounted for as other noncurrent assets. Assets held in trust related to this non-qualified pension plan were $484 and $1,065 at December 31, 2025 and 2024, respectively.
Non-U.S. Pension Plans
The Company provides pension and similar benefits to employees of certain non-U.S. subsidiaries consistent with local practices. Pension benefits earned are generally based on years of service and compensation during active employment.
The following table sets forth a reconciliation of the benefit obligation, plan assets, and funded status related to U.S. and non-U.S. pension plans:
| December 31, 2025 · December 31, 2024 | ||||||
|---|---|---|---|---|---|---|
| U.S. Plans · Non-U.S. Plans · U.S. Plans · Non-U.S. Plans | ||||||
| Change in benefit obligation: | ||||||
| Benefit obligation at beginning of year | $28,638 | $195,691 | $30,691 | $210,783 | ||
| Service cost | - | 2,975 | - | 3,121 | ||
| Interest cost | 1,520 | 6,601 | 1,525 | 6,698 | ||
| Plan amendments | - | 1,540 | - | 44 | ||
| Actuarial (gains) losses | 746 | (10,591) | (425) | 1,719 | ||
| Benefits paid | (3,179) | (11,776) | (3,153) | (14,508) | ||
| Curtailments and settlements | - | (4,601) | - | (98) | ||
| Currency translation | - | 17,988 | - | (12,068) | ||
| Benefit obligation at end of year | $27,725 | $197,827 | $28,638 | $195,691 | ||
| Change in plan assets: | ||||||
| Fair value of plan assets at beginning of year | $ | - | $64,468 | $ | - | $63,287 |
| Actual return on plan assets | - | 4,012 | - | 5,504 | ||
| Company contributions | 3,179 | 11,920 | 3,153 | 13,311 | ||
| Benefits paid | (3,179) | (11,776) | (3,153) | (14,509) | ||
| Curtailments and settlements | - | (4,398) | - | - | ||
| Currency translation | - | 2,008 | - | (3,125) | ||
| Fair value of plan assets at end of year | $ | - | $66,234 | $ | - | $64,468 |
| Funded status at end of year | $(27,725) | $(131,593) | $(28,638) | $(131,223) | ||
The plan assets are stated at fair value. See Note 18 for further discussion of the valuation of the plan assets.
Amounts recognized in the accompanying consolidated balance sheets consist of the following:
| December 31, 2025 · December 31, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| U.S. Plans · Non-U.S. Plans · U.S. Plans · Non-U.S. Plans | ||||||||
| Other assets | $ | - | $ | 2,507 | $ | - | $ | 1,216 |
| Accrued benefit liability - current | (132) | (7,970) | (880) | (6,720) | ||||
| Accrued benefit liability - non-current | (27,593) | (126,130) | (27,758) | (125,719) | ||||
| Accumulated other comprehensive loss | 574 | 8,177 | 11 | 18,861 | ||||
| $ | (27,151) | $ | (123,416) | $ | (28,627) | $ | (112,362) | |
Actuarial items consist of the following:
| December 31, 2025 · December 31, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| U.S. Plans · Non-U.S. Plans · U.S. Plans · Non-U.S. Plans | ||||||||
| Unrecognized net actuarial (gain) loss | $ | 574 | $ | 7,488 | $ | 11 | $ | 18,161 |
| Unamortized prior service cost | - | 689 | - | 700 | ||||
| $ | 574 | $ | 8,177 | $ | 11 | $ | 18,861 | |
The following table sets forth additional information regarding the projected and accumulated benefit obligations:
| December 31, 2025 | December 31, 2024 | |||
|---|---|---|---|---|
| U.S. Plans | Non-U.S. Plans | U.S. Plans | Non-U.S. Plans | |
| Accumulated benefit obligation, all plans | $27,725 | $183,128 | $28,638 | $180,542 |
| Plans for which the accumulated benefit obligation exceeds plan assets: | ||||
| Projected benefit obligation | $27,725 | $130,866 | $28,638 | $129,686 |
| Accumulated benefit obligation | 27,725 | 129,443 | 28,638 | 128,182 |
| Fair value of plan assets | - | - | - | - |
The following table sets forth the components of net periodic pension cost:
| Years ended December 31, | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2025 · 2024 · 2023 | |||||||||
| U.S. Plans · Non-U.S. Plans · U.S. Plans · Non-U.S. Plans · U.S. Plans · Non-U.S. Plans | |||||||||
| Service cost | $ | - | $2,975 | $ | - | $3,121 | $ | - | $3,063 |
| Interest cost | 1,520 | 6,601 | 1,525 | 6,698 | 1,997 | 7,346 | |||
| Expected return on plan assets | - | (2,436) | - | (2,347) | - | (2,270) | |||
| Amortization of actuarial (gains) losses | 183 | 1,024 | (1,026) | 1,799 | 175 | 345 | |||
| Amortization of prior service cost | - | 144 | 66 | 597 | 144 | 195 | |||
| Curtailment and settlement losses | - | 302 | - | 290 | - | 546 | |||
| Net periodic pension cost | $1,703 | $8,610 | $565 | $10,158 | $2,316 | $9,225 | |||
See Note 10 for the pretax, tax effect and after tax amounts included in other comprehensive income during the years ended December 31, 2025, 2024, and 2023. The estimated actuarial items for the defined benefit pensions plans that will be amortized from accumulated other comprehensive loss into net periodic pension cost during 2026 are not material.
The following weighted average assumptions were used to determine benefit obligations at December 31 of the respective years:
| 2025 | 2024 | |||
|---|---|---|---|---|
| U.S. Plans | Non-U.S. Plans | U.S. Plans | Non-U.S. Plans | |
| Discount rate | 5.25% | 3.80% | 5.50% | 3.43% |
| Rate of compensation increase | 0.00% | 3.06% | 0.00% | 3.37% |
The following weighted average assumptions were used to determine the net periodic pension costs:
| Years ended December 31, | ||||
|---|---|---|---|---|
| 2025 | 2024 | |||
| U.S. Plans | Non-U.S. Plans | U.S. Plans | Non-U.S. Plans | |
| Discount rate | 5.50% | 3.43% | 5.25% | 3.36% |
| Rate of compensation increase | 0.00% | 3.37% | 0.00% | 3.12% |
| Expected return on plan assets | 0.00% | 3.44% | 0.00% | 3.41% |
The plans’ expected return on assets is based on management’s expectations of long-term average rates of return to be achieved by the underlying investment portfolios. In establishing this assumption, management considers historical and expected returns for the asset classes in which the plans are invested, advice from pension consultants and investment advisors, and current economic and capital market conditions.
The investment mix between equity securities and fixed income securities is based upon achieving a desired return, balancing higher return, more volatile equity securities, and lower return, less volatile fixed income securities and is adjusted for the expected duration of the obligation and the funded status of the plan. Investment allocations are made across a range of securities, maturities and credit quality. The Company’s non-U.S. defined benefit plan investments are based on local laws and customs. Most plans invest in cash and local government fixed income securities, although plans in certain countries have investments in equity securities. The plans do not invest in securities of Vishay or its subsidiaries. Negative investment returns could ultimately affect the funded status of the plans, requiring additional cash contributions. See Note 18 for further information on the fair value of the plan assets by asset category.
Estimated future benefit payments are as follows:
| U.S. Plans · Non-U.S. Plans | ||
|---|---|---|
| 2026 | $2,036 | $31,405 |
| 2027 | 2,022 | 13,935 |
| 2028 | 1,961 | 14,990 |
| 2029 | 8,797 | 15,116 |
| 2030 | 3,147 | 15,598 |
| 2031-2036 | 8,798 | 68,034 |
The Company’s anticipated 2026 contributions for U.S. defined benefit pension plans are expected to be $2,036. The Company's anticipated 2026 contributions for Non-U.S. defined benefit plans are expected to be $19,770.
Other Postretirement Benefits
In the U.S., the Company maintains unfunded non-pension postretirement plans, including medical benefits for certain executives and their surviving spouses, which are funded as costs are incurred. The Company also maintainstwo unfunded non-pension postretirement plans attwo European subsidiaries.
The following table sets forth a reconciliation of the benefit obligation, plan assets, and accrued benefit cost related to U.S. and non-U.S. non-pension defined benefit postretirement plans:
| December 31, 2025 · December 31, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| U.S. Plans · Non-U.S. Plans · U.S. Plans · Non-U.S. Plans | ||||||||
| Change in benefit obligation: | ||||||||
| Benefit obligation at beginning of year | $3,938 | $7,086 | $4,260 | $7,563 | ||||
| Service cost | 8 | 237 | 21 | 241 | ||||
| Interest cost | 202 | 239 | 210 | 245 | ||||
| Actuarial (gains) losses | (1,553) | (395) | (43) | (169) | ||||
| Benefits paid | (530) | (902) | (510) | (344) | ||||
| Currency translation | - | 891 | - | (450) | ||||
| Benefit obligation at end of year | $2,065 | $7,156 | $3,938 | $7,086 | ||||
| Fair value of plan assets at end of year | $ | - | $ | - | $ | - | $ | - |
| Funded status at end of year | $(2,065) | $(7,156) | $(3,938) | $(7,086) | ||||
Amounts recognized in the accompanying consolidated balance sheets consist of the following:
| December 31, 2025 · December 31, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| U.S. Plans · Non-U.S. Plans · U.S. Plans · Non-U.S. Plans | ||||||||
| Accrued benefit liability - current | $ | (221) | $ | (1,027) | $ | (520) | $ | (799) |
| Accrued benefit liability - non-current | (1,844) | (6,129) | (3,418) | (6,287) | ||||
| Accumulated other comprehensive (income) loss | (2,675) | 788 | (1,329) | 1,158 | ||||
| $ | (4,740) | $ | (6,368) | $ | (5,267) | $ | (5,928) | |
Actuarial items consist of the following:
| December 31, 2025 · December 31, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| U.S. Plans · Non-U.S. Plans · U.S. Plans · Non-U.S. Plans | ||||||||
| Unrecognized net actuarial loss (gain) | $ | (2,675) | $ | 788 | $ | (1,329) | $ | 1,158 |
| $ | (2,675) | $ | 788 | $ | (1,329) | $ | 1,158 | |
The following table sets forth the components of net periodic benefit cost:
| Years ended December 31, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | 2023 | ||||
| U.S. Plans | Non-U.S. Plans | U.S. Plans | Non-U.S. Plans | U.S. Plans | Non-U.S. Plans | |
| Service cost | $8 | $237 | $21 | $241 | $21 | $221 |
| Interest cost | 202 | 239 | 210 | 245 | 225 | 251 |
| Amortization of actuarial (gains) losses | (208) | 59 | (240) | 82 | (321) | 8 |
| Curtailment and settlement losses | - | 141 | - | - | - | 89 |
| Net periodic benefit cost (benefit) | $2 | $676 | $(9) | $568 | $(75) | $569 |
The estimated actuarial items for the other postretirement benefit plans that will be amortized from accumulated other comprehensive loss into net periodic benefit cost during 2026 are not material.
The following weighted average assumptions were used to determine benefit obligations at December 31 of the respective years:
| 2025 | 2024 | |||
|---|---|---|---|---|
| U.S. Plans | Non-U.S. Plans | U.S. Plans | Non-U.S. Plans | |
| Discount rate | 5.25% | 3.77% | 5.50% | 3.25% |
| Rate of compensation increase | 0.00% | 3.50% | 0.00% | 3.50% |
The following weighted average assumptions were used to determine the net periodic benefit costs:
| Years ended December 31, | ||||
|---|---|---|---|---|
| 2025 | 2024 | |||
| U.S. Plans | Non-U.S. Plans | U.S. Plans | Non-U.S. Plans | |
| Discount rate | 5.50% | 3.25% | 5.25% | 3.40% |
| Rate of compensation increase | 0.00% | 3.50% | 0.00% | 4.00% |
The impact of a one-percentage-point change in assumed health care cost trend rates on the net periodic benefit cost and postretirement benefit obligation is not material.
Estimated future benefit payments are as follows:
| U.S. Plans · Non-U.S. Plans | ||
|---|---|---|
| 2026 | $221 | $1,027 |
| 2027 | 203 | 854 |
| 2028 | 187 | 590 |
| 2029 | 220 | 186 |
| 2030 | 204 | 1,023 |
| 2031-2036 | 812 | 4,811 |
As the plans are unfunded, the Company’s anticipated contributions for 2026 are equal to its estimated benefits payments.
Other Retirement Obligations
The Company participates in various other defined contribution and government-mandated retirement plans based on local law or custom. The Company periodically makes required contributions for certain of these plans, whereas other plans are unfunded retirement bonus plans which will be paid at the employee's retirement date. At December 31, 2025 and 2024, the accompanying consolidated balance sheets include $11,027 and $10,518, respectively, within accrued pension and other postretirement costs related to these plans.
The Company’s U.S. employees are eligible to participate in a 401(k) savings plan, which provides for Company matching contributions. The Company’s matching expense for the plans was $7,821, $7,915, and $7,641 for the years ended December 31, 2025, 2024, and 2023, respectively. No material amounts are included in the accompanying consolidated balance sheets at December 31, 2025 and 2024 related to unfunded 401(k) contributions.
Certain key employees participate in a deferred compensation plan. During the years ended December 31, 2025, 2024, and 2023, these employees could defer a portion of their compensation until retirement, or elect shorter deferral periods. The Company maintains a liability within other noncurrent liabilities on its consolidated balance sheets related to these deferrals. The Company maintains a non-qualified trust, referred to as a “rabbi” trust, to fund payments under this plan. Rabbi trust assets are subject to creditor claims under certain conditions and are not the property of employees. Therefore, they are accounted for as other noncurrent assets. Assets held in trust related to the deferred compensation plan at December 31, 2025 and 2024 were approximately $34,891 and $32,601, respectively.
Note 12 – Stock-Based Compensation
2023 Long-Term Incentive Plan
The Company implemented the Vishay Intertechnology, Inc. 2023 Long-Term Incentive Plan (the "2023 Plan") after receiving stockholder approval at its 2023 Annual Meeting of Stockholders on May 23, 2023. The 2023 Plan allows the Company to grant up to 6,000,000 shares (subject to certain adjustments described in the 2023 Plan) of stock options, stock appreciation rights, restricted stock, restricted stock units, other stock-based awards, phantom stock units, and other cash-based awards to employees, directors, consultants, and other service providers of the Company and its affiliates. Such instruments are available for grant until March 24, 2033. At December 31, 2025, the Company has reserved 1,524,000 shares of common stock for future grants of equity awards pursuant to the 2023 Plan.
2007 Stock Incentive Program
Under the Company's 2007 Stock Incentive Program (the "2007 Program"), as amended and restated, certain executive officers and board members of the Company were granted restricted stock units. No further awards will be granted pursuant to the 2007 Program. Pursuant to the terms of the 2023 Plan, any shares of common stock that are subject to outstanding awards granted pursuant to the 2007 Program that subsequently cease to be subject to such awards as a result of the termination, expiration, cancellation, or forfeiture of such awards and any shares of common stock withheld in settlement of tax withholding obligations associated with outstanding awards granted pursuant to the 2007 Program may become available for issuance under the 2023 Plan.
All RSUs granted pursuant to the 2007 Program and the 2023 Plan contain service vesting conditions. Certain RSUs also contain performance or market vesting conditions. The Company recognizes compensation cost for RSUs that are expected to vest and records cumulative adjustments in the period that the expectation changes.
The following table summarizes share-based compensation expense recognized:
| Years ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Restricted stock units | $22,272 | $20,803 | $16,425 |
| Phantom stock units | 83 | 118 | 107 |
| Total | $22,355 | $20,921 | $16,532 |
The following table summarizes unrecognized compensation cost and the weighted average remaining amortization periods at December 31, 2025(amortization periods in years):
| Unrecognized Compensation Cost | Weighted Average Remaining Amortization Periods | |
|---|---|---|
| Restricted stock units | $26,940 | 1.9 |
| Phantom stock units | - | - |
| Total | $26,940 |
The Company currently expects all of the unrecognized compensation cost presented in the table above to be recognized.
Note 12 – Stock-Based Compensation (continued)
Restricted Stock Units
Each RSU entitles the recipient to receive a share of common stock when the RSU vests.
RSU activity is presented below(number of RSUs in thousands):
| Years ended December 31, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | 2023 | ||||
| Number of RSUs | Weighted Average Grant-date Fair Value | Number of RSUs | Weighted Average Grant-date Fair Value | Number of RSUs | Weighted Average Grant-date Fair Value | |
| Outstanding: | ||||||
| Beginning of year | 2,628 | $21.37 | 1,717 | $23.03 | 894 | $19.73 |
| Granted* | 1,889 | 15.12 | 1,665 | 20.39 | 1,180 | 24.34 |
| Vested** | (782) | 21.78 | (613) | 22.95 | (342) | 18.86 |
| Cancelled or forfeited | (250) | 19.80 | (141) | 23.14 | (15) | 24.83 |
| End of year | 3,485 | $18.00 | 2,628 | $21.37 | 1,717 | $23.03 |
| Expected to vest | 2,251 | 1,876 | 1,702 | |||
- Employees in certain countries are granted equity-linked awards that will be settled in cash and are accounted for as liability awards. The liability awards are not material. The number of RSUs granted excludes these awards.
** The number of RSUs vested includes shares that the Company withheld on behalf of employees to satisfy the statutory tax withholding requirements.
The number of performance-based RSUs that are scheduled to vest increases ratably based on the achievement of defined performance and market criteria between the established target and maximum levels. RSUs with performance-based and market-based vesting criteria are expected to vest as follows(number of RSUs in thousands):
| Vesting Date | Expected to Vest | Not Expected to Vest | Total |
|---|---|---|---|
| January 1, 2026*** | - | 137 | 137 |
| January 1, 2027 | - | 526 | 526 |
| January 1, 2028 | 468 | 396 | 864 |
| March 1, 2029 | - | 175 | 175 |
*** The performance vesting criteria for the performance-based RSUs with a vesting date of January 1, 2026 were not achieved.
RSUs, including those with performance-based and market-based vesting criteria, generally vest over three years, provided that vesting may accelerate in certain cases, such as in connection with a qualifying retirement or certain involuntary terminations of employment, with certain variation of criteria for executive officers and non-executive employees.
Note 12 – Stock-Based Compensation (continued)
Phantom Stock Units
Each phantom stock unit entitles the recipient to receive a share of common stock at the individual's termination of employment or any other future date specified in the applicable employment agreement. Phantom stock units participate in dividend distribution on the same basis as the Company's common stock and Class B common stock. Dividend equivalents are issued in the form of additional units of phantom stock. The phantom stock units are fully vested at all times.
The following table summarizes the Company’s phantom stock units activity(number of phantom stock units in thousands):
| Years ended December 31, | |||||||
|---|---|---|---|---|---|---|---|
| 2025 · 2024 · 2023 | |||||||
| Number of Phantom Stock Units · Grant-date Fair Value per Unit · Number of Phantom Stock Units · Grant-date Fair Value per Unit · Number of Phantom Stock Units · Grant-date Fair Value per Unit | |||||||
| Outstanding: | |||||||
| Beginning of year | 128 | 120 | 226 | ||||
| Granted | 5 | $16.69 | 5 | $23.51 | 5 | $21.48 | |
| Dividend equivalents issued | 3 | 3 | 2 | ||||
| Redeemed for common stock* | - | - | (113) | ||||
| End of year | 136 | 128 | 120 | ||||
- The number of phantom stock units redeemed for common stock includes shares that the Company withheld on behalf of employees to satisfy the statutory tax withholding requirements.
Note 13 – Commitments and Contingencies
Environmental Matters
The Company is subject to various federal, state, local, and foreign laws and regulations governing environmental matters, including the use, discharge, and disposal of hazardous materials. The Company’s manufacturing facilities are believed to be in substantial compliance with current laws and regulations. Complying with current laws and regulations has not had a material adverse effect on the Company’s financial condition.
The Company has engaged environmental consultants and attorneys to assist management in evaluating potential liabilities related to environmental matters. Management assesses the input from these consultants along with other information known to the Company in its effort to continually monitor these potential liabilities. Management assesses its environmental exposure on a site-by-site basis, including those sites where the Company has been named as a “potentially responsible party.” Such assessments include the Company’s share of remediation costs, information known to the Company concerning the size of the hazardous waste sites, their years of operation, and the number of past users and their financial viability.
As of December 31, 2025, the Company has accrued environmental liabilities of $14,468, of which $5,626 is included inother accrued liabilities on the accompanying consolidated balance sheet, and $8,842 is included inother noncurrent liabilities on the accompanying consolidated balance sheet.
While the ultimate outcome of these matters cannot be determined, management does not believe that the final disposition of these matters will have a material adverse effect on the Company’s consolidated financial position, results of operations, or cash flows. The Company’s present and past facilities have been in operation for many years. These facilities have used substances and have generated and disposed of wastes which are or might be considered hazardous. Therefore, it is possible that additional environmental issues may arise in the future, which the Company cannot now predict.
Litigation
The Company is a party to various claims and lawsuits arising in the normal course of business. The Company is of the opinion that these litigations or claims will not have a material negative effect on its consolidated financial position, results of operations, or cash flows.
Long-Term Purchase Agreements
The Company maintains long-term purchase agreements with subcontractors, suppliers, and other business partners to ensure access to external capacity and supply. The Company has minimum purchase commitments pursuant to certain of its long-term arrangements with its subcontractors and other suppliers and business partners of $71,806, $15,563, $1,766 and for the years 2026 through 2028, respectively. The Company has the option to purchase amounts in addition to the minimum commitment and, accordingly, actual purchases may be different than the amounts disclosed above. The Company exceeded its minimum purchase commitments in 2025.
Product Quality Claims
The Company is a party to various product quality claims in the normal course of business. See Note 1 for further information on the Company's warranty obligations.
Executive Employment Agreements
The Company has employment agreements with certain of its senior executives. These employment agreements provide incremental compensation in the event of termination. The Company does not provide any severance or other benefits specifically upon a change in control.
Note 14 – Current Vulnerability Due to Certain Concentrations
Market Concentrations
No customer represented greater than 10% of consolidated net revenue in 2025, 2024, or 2023.
A material portion of the Company's revenues are derived from the worldwide industrial, automotive, telecommunications, and computing markets. These markets have historically experienced wide variations in demand for end products. If demand for these end products should decrease, the producers thereof could reduce their purchases of the Company's products, which could have an adverse effect on the Company's results of operations and financial position.
Certain subsidiaries and product lines have customers which comprise greater than 10% of the subsidiary's or product line's net revenues. The loss of one of these customers could have a material effect on the results of operations of the subsidiary or product line and financial position of the subsidiary, which could result in an impairment charge which could be material to the Company's consolidated financial statements.
Credit Risk Concentrations
Financial instruments with potential credit risk consist principally of cash and cash equivalents, short-term investments, accounts receivable, and notes receivable. Concentrations of credit risk with respect to receivables are generally limited due to the Company’s large number of customers and their dispersion across many countries and industries. As of December 31, 2025, one customer comprised 12.8% of the Company's accounts receivable balance. No customer comprised greater than 10% of the Company's accounts receivable balance as of December 31, 2024. The Company continually monitors the credit risks associated with its accounts receivable and adjusts the allowance for uncollectible accounts accordingly. The credit risk exposure associated with the accounts receivable is limited by the allowance and is not considered material to the financial statements.
The Company maintains cash and cash equivalents and short-term investments with various major financial institutions. The Company is exposed to credit risk related to the potential inability to access liquidity in financial institutions where its cash and cash equivalents and short-term investments are concentrated. As of December 31, 2025, the following financial institutions held over 10% of the Company’s combined cash and cash equivalents and short-term investments balance:
| JPMorgan* | 23.1% |
|---|---|
| MUFG Bank Ltd.* | 20.9% |
| HSBC* | 18.2% |
*Participant in Credit Facility
Sources of Supplies
The production and sale of the Company’s products is reliant on a complex global interconnected supply chain of vendors, manufacturing facilities, third-party foundries and subcontractors, shipping partners, distributors, and end market customers. Disruption in one part of the supply chain could cause disruption in all other parts of the supply chain. Global shipping impacts several parts of the supply chain and the disruption experienced in recent years has, at times, negatively impacted the Company’s ability to manufacture products and to deliver them to customers.
Although most materials incorporated into the Company's products are available from a number of sources, certain materials, including plastics and metals, are produced in only a limited number of regions around the world or are available from only a limited number of suppliers. Suppliers periodically extend lead times, face capacity constraints, limit supplies, increase prices, experience quality issues, or encounter cybersecurity or other issues that can interrupt or increase the cost of our supply. The unavailability or reduced availability of these materials could require the Company to temporarily cease or reduce production or incur additional costs.
Customer requirements and certain laws pertaining to the responsible sourcing of materials, including tantalum, tungsten, tin, gold, and cobalt, all of which are used in the Company’s products, are increasing and becoming more stringent. Responsible sourcing efforts may result in increased prices and decreased availability of these materials.
Many of the metals used in the manufacture of the Company’s products, including gold, copper, and palladium, are traded on active markets and can be subject to significant price volatility. To ensure adequate supply and to provide cost certainty, the Company’s policy is to enter into short-term commitments to purchase defined portions of annual consumption of the raw materials utilized if market prices decline below budget. If after entering into these commitments, the market prices for these raw materials decline, losses are recognized on these adverse purchase commitments.
Note 14 – Current Vulnerability Due to Certain Concentrations (continued)
The Company's production can be disrupted by the unavailability of resources, such as water, energy, and gases. The unavailability or reduced availability of these resources could require the Company to reduce production or incur additional costs.
The Company uses third-party foundries and subcontractors for certain of its manufacturing activities, primarily wafer fabrication, the assembly and testing of finished goods, and the manufacturing of certain commodity products. Establishing third-party contract manufacturer relationships can be time consuming and costly, and the number of qualified providers is limited. The Company's agreements with these manufacturers typically require it to commit to purchase services based on forecasted product needs, which may be inaccurate, and, in some cases, require the recognition of losses on these adverse purchase commitments. The Company's agreements may limit its ability to increase production, particularly during periods of growing demand for our products.
Geographic Concentration
The Company has operations outside the United States, and approximately 76% of revenues earned during 2025 were derived from sales to customers outside the United States. Additionally, as of December 31, 2025, $501,856 of the Company’s cash and cash equivalents and short-term investments were held by subsidiaries outside of the United States. Some of the Company’s products are produced and cash and cash equivalents and short-term investments are held in countries which are subject to risks of political, economic, and military instability. This instability could result in wars, riots, nationalization of industry, currency fluctuations, and labor unrest. These conditions could have an adverse impact on the Company’s ability to operate in these regions and, depending on the extent and severity of these conditions, could materially and adversely affect the Company’s overall financial condition, operating results, and ability to access its liquidity when needed.
As of December 31, 2025, the Company’s cash and cash equivalents and short-term investments were concentrated in the following countries:
| Singapore | 27.3% |
|---|---|
| People's Republic of China | 21.6% |
| The Republic of China (Taiwan) | 15.0% |
| Germany | 9.9% |
| Israel | 8.6% |
| United States | 4.5% |
| Malaysia | 3.9% |
| Other Asia | 5.1% |
| Other Europe | 2.0% |
| Other | 2.1% |
Certain of the Company's non-U.S. subsidiaries have cash and cash equivalents and short-term investments deposited in U.S. financial institutions. Of the 4.5% of cash and cash equivalents and short-term investments held in U.S. financial institutions, $20,669 was held by non-U.S. subsidiaries.
Vishay has been in operation in Israel for 55 years. The Company has never experienced any material interruption in its operations attributable to these factors, in spite of several Middle East crises, including wars.
Note 15 – Segment and Geographic Data
Vishay is a global manufacturer and supplier of electronic components. Vishay operates, and its chief operating decision maker makes strategic and operating decisions with regards to assessing performance and allocating resources based on, six reporting segments: MOSFETs, Diodes, Optoelectronic Components, Resistors, Inductors, and Capacitors. These segments represent groupings of product lines based on their functionality:
| ● | Metal oxide semiconductor field effect transistors ("MOSFETs") function as solid state switches to control power. |
|---|---|
| ● | Diodes route, regulate, and block radio frequency, analog, and power signals; protect systems from surges or electrostatic discharge damage; or provide electromagnetic interference filtering. |
| ● | Optoelectronic components emit light, detect light, or do both. |
| ● | Resistors are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current. |
| ● | Inductors use an internal magnetic field to change alternating current phase and resist alternating current. |
| ● | Capacitors store energy and discharge it when needed. |
Vishay's reporting segments generate substantially all of their revenue from product sales to the industrial, automotive, telecommunications, computing, consumer products, power supplies, military and aerospace, and healthcare end markets. An immaterial portion of revenues are from royalties.
The Company’s chief operating decision maker is its President and Chief Executive Officer. The chief operating decision maker uses both gross profit and operating income, exclusive of certain items ("segment operating income") to make decisions, allocate resources, and assess performance, and the Company thus considers segment gross profit and operating income to be its measures of segment profit or loss. Only dedicated, direct selling, general, and administrative expenses of the segments are included in the calculation of segment operating income. The Company's calculation of segment operating income excludes selling, general, and administrative costs of its global operations, sales and marketing, information systems, finance, and administration groups, as well as restructuring and severance costs, goodwill impairment charges, and other items affecting comparability. Management believes that evaluating segment performance excluding such items is meaningful because it provides insight with respect to intrinsic operating results of the Company. These items represent reconciling items between segment operating income and consolidated operating income. Business segment assets are the owned or allocated assets used by each business.
Cost of products sold (excluding depreciation) is defined as the aggregate costs incurred in the production of goods for sale, excluding depreciation expense.
Depreciation expense in cost of products sold is defined as the aggregate expense recognized for the allocation of costs of tangible assets used in the production of goods to the periods that benefit from the use of the assets. It excludes depreciation expense attributed to selling, general, and administrative activities.
Segment gross profit is calculated as net revenues determined based on the U.S. GAAP definition, minus costs of goods sold and depreciation expense, as defined above.
Segment operating expenses is defined as the dedicated, direct selling, general, and administrative expenses, including research and development expenses attributed to the segment.
The following tables set forth business segment information:
| MOSFETs · Diodes · Optoelectronic Components · Resistors · Inductors · Capacitors · Corporate / Other · Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Year ended December 31, 2025: | |||||||||
| Net revenues | $630,463 | $592,757 | $216,551 | $759,343 | $364,374 | $505,560 | $ | - | $3,069,048 |
| Cost of products sold (excluding depreciation) | $514,631 | $426,449 | $156,391 | $553,777 | $247,154 | $379,229 | $ | - | $2,277,631 |
| Depreciation expense in cost of products sold | 54,234 | 47,066 | 15,817 | 44,794 | 16,938 | 17,685 | - | 196,534 | |
| Total cost of products sold | 568,865 | 473,515 | 172,208 | 598,571 | 264,092 | 396,914 | - | 2,474,165 | |
| Gross profit | 61,598 | 119,242 | 44,343 | 160,772 | 100,282 | 108,646 | - | 594,883 | |
| Segment operating expenses | $92,157 | $29,548 | $22,398 | $37,710 | $15,438 | $25,832 | $ | - | $223,083 |
| Segment operating income (loss) | $(30,559) | $89,694 | $21,945 | $123,062 | $84,844 | $82,814 | $ | - | $371,800 |
| Total depreciation expense | $56,913 | $48,349 | $16,272 | $45,532 | $17,371 | $17,851 | $9,254 | $211,542 | |
| Capital expenditures | 182,367 | 31,936 | 8,938 | 21,300 | 4,358 | 20,881 | 3,513 | 273,293 | |
| Total assets as of December 31, 2025: | $1,167,383 | $717,696 | $346,449 | $940,942 | $322,652 | $454,319 | $284,719 | $4,234,160 | |
| Year ended December 31, 2024: | |||||||||
| Net revenues | $601,979 | $581,975 | $212,368 | $725,614 | $356,355 | $459,296 | $ | - | $2,937,587 |
| Cost of products sold (excluding depreciation) | $465,536 | $414,893 | $158,742 | $524,808 | $231,456 | $330,460 | $ | - | $2,125,895 |
| Depreciation expense in cost of products sold | 49,342 | 45,920 | 15,374 | 41,848 | 17,819 | 15,097 | - | 185,400 | |
| Total cost of products sold | 514,878 | 460,813 | 174,116 | 566,656 | 249,275 | 345,557 | - | 2,311,295 | |
| Gross profit | 87,101 | 121,162 | 38,252 | 158,958 | 107,080 | 113,739 | - | 626,292 | |
| Segment operating expenses | $80,243 | $25,281 | $21,393 | $33,217 | $14,818 | $23,469 | $ | - | $198,421 |
| Segment operating income | $6,858 | $95,881 | $16,859 | $125,741 | $92,262 | $90,270 | $ | - | $427,871 |
| Total depreciation expense | $51,301 | $47,099 | $15,784 | $42,568 | $17,940 | $15,293 | $8,976 | $198,961 | |
| Capital expenditures | 224,998 | 29,534 | 10,451 | 30,301 | 6,339 | 13,609 | 4,847 | 320,079 | |
| Total assets as of December 31, 2024: | $1,033,555 | $724,603 | $346,866 | $958,985 | $342,286 | $430,871 | $273,530 | $4,110,696 | |
| Year ended December 31, 2023: | |||||||||
| Net revenues | $778,754 | $690,540 | $243,146 | $843,472 | $347,392 | $498,741 | $ | - | $3,402,045 |
| Cost of products sold (excluding depreciation) | $485,086 | $471,088 | $164,791 | $566,640 | $220,090 | $358,120 | $ | - | $2,265,815 |
| Depreciation expense in cost of products sold | 34,282 | 43,831 | 16,129 | 38,404 | 14,888 | 14,203 | - | 161,737 | |
| Total cost of products sold | 519,368 | 514,919 | 180,920 | 605,044 | 234,978 | 372,323 | - | 2,427,552 | |
| Gross profit | 259,386 | 175,621 | 62,226 | 238,428 | 112,414 | 126,418 | - | 974,493 | |
| Segment operating expenses | $63,593 | $22,159 | $19,263 | $29,003 | $12,730 | $21,433 | $ | - | $168,181 |
| Segment operating income | $195,793 | $153,462 | $42,963 | $209,425 | $99,684 | $104,985 | $ | - | $806,312 |
| Total depreciation expense | $35,965 | $44,904 | $16,496 | $39,781 | $14,963 | $14,269 | $8,079 | $174,457 | |
| Capital expenditures | 132,543 | 62,185 | 23,228 | 67,085 | 10,767 | 21,914 | 11,688 | 329,410 | |
| Total assets as of December 31, 2023: | $702,299 | $852,703 | $352,984 | $946,585 | $365,111 | $459,653 | $560,588 | $4,239,923 | |
| Years ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Reconciliation: | |||
| Segment Operating Income | $371,800 | $427,871 | $806,312 |
| Restructuring and Severance Costs | - | (40,614) | - |
| Impairment of Goodwill | - | (66,487) | - |
| Unallocated Selling, General, and Administrative Expenses | (314,932) | (315,143) | (320,168) |
| Consolidated Operating Income | $56,868 | $5,627 | $486,144 |
| Unallocated Other Income (Expense) | (31,355) | (8,016) | (18,742) |
| Consolidated Income (Loss) Before Taxes | $25,513 | $(2,389) | $467,402 |
The Company has a broad line of products that it sells to OEMs, EMS companies, and independent distributors. The distribution of sales by customer type is shown below:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Distributors | $1,716,235 | $1,578,172 | $1,798,291 |
| OEMs | 1,147,048 | 1,156,852 | 1,378,065 |
| EMS companies | 205,765 | 202,563 | 225,689 |
| $3,069,048 | $2,937,587 | $3,402,045 | |
Net revenues were attributable to customers in the following regions:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Asia | $1,294,853 | $1,149,138 | $1,255,563 |
| Europe | 1,028,072 | 1,029,901 | 1,255,652 |
| Americas | 746,123 | 758,548 | 890,830 |
| $3,069,048 | $2,937,587 | $3,402,045 | |
The Company generates substantially all of its revenue from product sales to end customers in the industrial, automotive, military and aerospace, healthcare, power supplies, telecommunications, consumer products, and computing end markets. Sales by end market are presented below:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Industrial | $1,064,404 | $992,192 | $1,216,078 |
| Automotive | 1,088,090 | 1,097,713 | 1,202,923 |
| Military and Aerospace | 314,128 | 325,318 | 271,871 |
| Healthcare | 152,065 | 147,845 | 152,611 |
| Other* | 450,361 | 374,519 | 558,562 |
| $3,069,048 | $2,937,587 | $3,402,045 | |
*Power supplies, telecommunications, consumer products, and computing
The following table summarizes net revenues based on revenues generated by subsidiaries located within the identified geographic area:
| Years ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| United States | $768,085 | $761,218 | $879,734 |
| Germany | 904,162 | 871,479 | 1,076,812 |
| Other Europe | 108,079 | 148,055 | 151,160 |
| Israel | 21,027 | 22,517 | 29,560 |
| Asia | 1,267,695 | 1,134,318 | 1,264,779 |
| $3,069,048 | $2,937,587 | $3,402,045 | |
The following table summarizes property and equipment based on physical location:
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| United States | $128,551 | $149,487 |
| Germany | 509,703 | 359,430 |
| United Kingdom | 246,323 | 214,838 |
| Other Europe | 154,862 | 137,109 |
| Israel | 99,017 | 109,277 |
| People's Republic of China | 207,662 | 236,068 |
| Republic of China (Taiwan) | 195,162 | 204,757 |
| Other Asia | 116,879 | 119,236 |
| Other | 15,000 | 15,536 |
| $1,673,159 | $1,545,738 | |
Note 16 – Earnings Per Share
Basic earnings per share is computed using the weighted average number of common shares outstanding during the periods presented. Diluted earnings per share is computed using the weighted average number of common shares outstanding adjusted to include the potentially dilutive effect of restricted stock units (see Note 12), convertible debt instruments (see Note 6), and other potentially dilutive securities.
The following table sets forth the computation of basic and diluted earnings (loss) per share attributable to Vishay stockholders(shares in thousands):
| Years ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Numerator: | |||
| Net earnings (loss) attributable to Vishay stockholders | $(8,978) | $(31,150) | $323,820 |
| Denominator: | |||
| Denominator for basic earnings (loss) per share: | |||
| Weighted average shares | 135,603 | 136,838 | 139,318 |
| Outstanding phantom stock units | 134 | 126 | 129 |
| Adjusted weighted average shares - basic | 135,737 | 136,964 | 139,447 |
| Effect of dilutive securities: | |||
| Restricted stock units | - | - | 799 |
| Dilutive potential common shares | - | - | 799 |
| Denominator for diluted earnings (loss) per share: | |||
| Adjusted weighted average shares - diluted | 135,737 | 136,964 | 140,246 |
| Basic earnings (loss) per share attributable to Vishay stockholders | $(0.07) | $(0.23) | $2.32 |
| Diluted earnings (loss) per share attributable to Vishay stockholders | $(0.07) | $(0.23) | $2.31 |
Diluted earnings (loss) per share for the years presented do not reflect the following weighted average potential common shares, as the effect would be antidilutive(in thousands):
| Years ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Restricted stock units | 3,306 | 2,423 | 82 |
If the average market price of Vishay common stock is less than the effective conversion price of the convertible senior notes due 2030 no shares are included in the diluted earnings per share computation for the convertible senior notes due 2030. Pursuant to the indenture governing the convertible senior notes due 2030, Vishay will satisfy its conversion obligations by paying $1 cash per $1 principal amount of converted notes and settle any additional amounts due in cash and/or common stock. Similarly, the convertible senior notes due 2025 were considered, but not included, in the diluted earnings per share computation for any period presented or any period they were outstanding.
In connection with the issuance of the convertible senior notes due 2030, the Company entered into capped call transactions (see Note 6), which were not included in the calculation of diluted earnings per share as their effect would have been anti-dilutive. The capped calls are intended to reduce the potential dilution to the Company's common stock in the event that at the time of conversion of the convertible senior notes due 2030 the Company's common stock price exceeds the conversion price of the convertible senior notes due 2030.
Note 17 – Additional Cash Flow Information
Changes in operating assets and liabilities, net of effects of businesses acquired, consist of the following:
| Years ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Accounts receivable | $39,346 | $17,525 | $(3,717) |
| Inventories | (74,927) | (78,496) | (58,758) |
| Prepaid expenses and other current assets | (4,667) | 45,611 | (42,005) |
| Accounts payable | (6,354) | 22,806 | 743 |
| Other current liabilities | 23,758 | (75,562) | (58,120) |
| Net change in operating assets and liabilities | $(22,844) | $(68,116) | $(161,857) |
Note 18 – Fair Value Measurements
The following table provides the financial assets and liabilities carried at fair value measured on a recurring basis:
| Total Fair Value · Level 1 · Level 2 · Level 3 | |||||
|---|---|---|---|---|---|
| Assets: | |||||
| Assets held in rabbi trusts | $55,442 | $22,749 | $32,693 | $ | - |
| Available for sale securities | $4,660 | 4,660 | - | - | |
| Non - U.S. Defined Benefit Pension Plan Assets: | |||||
| Equity securities | $3,114 | 3,114 | - | - | |
| Fixed income securities | $22,025 | 22,025 | - | - | |
| Cash | $41,095 | 41,095 | - | - | |
| $126,336 | $93,643 | $32,693 | $ | - | |
| Liability: | |||||
| Acquisitions contingent consideration | $2,938 | - | - | 2,938 | |
| Assets: | |||||
| Assets held in rabbi trusts | $53,508 | $24,518 | $28,990 | $ | - |
| Available for sale securities | $4,043 | 4,043 | - | - | |
| Non - U.S. Defined Benefit Pension Plan Assets: | |||||
| Equity securities | $4,174 | 4,174 | - | $ | - |
| Fixed income securities | $23,991 | 23,991 | - | - | |
| Cash | $36,303 | 36,303 | - | - | |
| $122,019 | $93,029 | $28,990 | $ | - | |
| Liability: | |||||
| Acquisitions contingent consideration | $3,801 | - | - | 3,801 | |
There have been no changes in the classification of any financial instruments within the fair value hierarchy in the periods presented.
During the third and fourth fiscal quarters of 2024, the Company performed quantitative goodwill impairment tests in which the fair value of the Company's reporting units was calculated. See additional information on the impairment tests in Note 19.
The Company maintains non-qualified trusts, referred to as “rabbi” trusts, to fund payments under deferred compensation and non-qualified pension plans. Rabbi trust assets consist primarily of marketable securities, classified as available-for-sale, and company-owned life insurance assets. The marketable securities held in the rabbi trusts are valued using quoted market prices on the last business day of the year. The company-owned life insurance assets are valued in consultation with the Company’s insurance brokers using the value of underlying assets of the insurance contracts. The fair value measurement of the marketable securities held in the rabbi trust is considered a Level 1 measurement and the measurement of the company-owned life insurance assets is considered a Level 2 measurement within the fair value hierarchy.
The Company maintains defined benefit retirement plans in certain of its non-U.S. subsidiaries. The assets of the plans are measured at fair value.
Equity securities held by the non-U.S. defined benefit retirement plans consist of equity securities that are valued based on quoted market prices on the last business day of the year. The fair value measurement of the equity securities is considered a Level 1 measurement within the fair value hierarchy.
Fixed income securities held by the non-U.S. defined benefit retirement plans consist of government bonds in the Philippines and India and corporate notes that are valued based on quoted market prices on the last business day of the year. The fair value measurement of the fixed income securities is considered a Level 1 measurement within the fair value hierarchy.
Cash held by the non-U.S. defined benefit retirement plans consists of demand deposits on account in various financial institutions to fund current benefit payments. The carrying amount of the cash approximates its fair value.
The Company holds investments in debt securities that are intended to fund a portion of its pension and other postretirement benefit obligations outside of the U.S. The investments are valued based on quoted market prices on the last business day of the year. The fair value measurement of the investments is considered a Level 1 measurement within the fair value hierarchy.
Note 18 – Fair Value Measurements (continued)
The Company may be required to make certain contingent consideration payments to related to acquisitions. The fair value of these contingent payments is determined by estimating the net present value of the expected cash flows based on the probability of expected payments. The fair value measurement of the contingent consideration payments is considered a Level 3 measurement within the fair value hierarchy.
The fair value of the long-term debt, excluding the deferred financing costs, at December 31, 2025 and 2024 is approximately $896,100 and $850,600, respectively, compared to its carrying value, excluding the deferred financing costs, of $969,000 and $927,911, respectively. The Company estimates the fair value of its long-term debt using a combination of quoted market prices for similar financing arrangements and expected future payments discounted at risk-adjusted rates, which are considered level 2 inputs.
At December 31, 2025 and 2024, the Company’s short-term investments were comprised of time deposits with financial institutions that have maturities that exceed 90 days from the date of acquisition; however they all mature within one year from the respective balance sheet dates. The Company's short-term investments are accounted for as held-to-maturity debt instruments, at amortized cost, which approximates their fair value. The investments are funded with excess cash not expected to be needed for operations prior to maturity; therefore, the Company believes it has the intent and ability to hold the short-term investments until maturity. At each reporting date, the Company performs an evaluation to determine if any unrealized losses are other-than-temporary. No other-than-temporary impairments have been recognized on these securities, and there areno unrecognized holding gains or losses for these securities during the periods presented. There have beenno transfers to or from the held-to-maturity classification. All decreases in the account balance are due to returns of principal at the securities’ maturity dates. Interest on the securities is recognized as interest income when earned.
At December 31, 2025 and 2024, the Company’s cash and cash equivalents were comprised of demand deposits, time deposits with maturities of three months or less when purchased, and money market funds. The Company estimates the fair value of its cash, cash equivalents, and short-term investments using level 2 inputs. Based on the current interest rates for similar investments with comparable credit risk and time to maturity, the fair value of the Company's cash, cash equivalents, and held-to-maturity short-term investments approximate the carrying amounts reported in the accompanying consolidated balance sheets.
The Company’s financial instruments also include accounts receivable and accounts payable. The carrying amounts for these financial instruments reported in the accompanying consolidated balance sheets approximate their fair values.
Note 19 – Goodwill and Other Intangible Assets
When required to perform quantitative goodwill impairment assessments, the Company estimates the fair value of each of its business segments, which represent its reporting units for goodwill impairment testing purposes, using mostly Level 3 inputs. Assessments are performed using a weighting of the income and market approaches to determine fair value. The Company uses a discounted cash flow (“DCF”) method, using unobservable inputs, as its income approach. The Company uses comparable company market multiples for its market approach. The resulting estimates of fair value from the income approach and the market approach are then weighted equally in determining the overall estimated fair value of each reporting unit.
The determination of the fair value of the reporting units and the allocation of that value to individual assets and liabilities within those reporting units requires the Company to make significant estimates and assumptions. These estimates and assumptions primarily include, but are not limited to: the selection of appropriate peer group companies; control premiums appropriate for acquisitions in the industries in which the Company competes; the discount rate; terminal growth rates; and forecasts of revenue, operating income, depreciation and amortization (components of earnings before interest, taxes, depreciation, amortization, "EBITDA"); and capital expenditures.
Due to the inherent uncertainty involved in making these estimates, actual financial results could differ from those estimates. Changes in assumptions concerning future financial results or other underlying assumptions could have a significant impact on results of the assessment.
We performed a qualitative annual impairment test in the fourth fiscal quarter of 2025. Based on the evaluation, it was determined that the fair value of the reporting units were not more likely than not less than their respective carrying amounts. No goodwill impairment charges were recognized in 2025 as a result.
In 2024, the Company determined that the fair value of its MOSFETs reporting unit was less than its carrying value. Accordingly, the Company recorded a goodwill impairment charge of $66,487. Prior to completing the goodwill impairment assessment, the Company performed a recoverability test of certain depreciable and amortizable long-lived assets within the MOSFETs reporting unit. There was no impairment identified for the depreciable and amortizable long-lived assets tested for recoverability.
The changes in the carrying amount of goodwill by segment for the years ended December 31, 2025 and 2024 were as follows:
| MOSFETs · Optoelectronic Components · Resistors · Inductors · Capacitors · Total | ||||||||
|---|---|---|---|---|---|---|---|---|
| Balance at December 31, 2023 | $34,246 | $96,849 | $44,506 | $25,815 | $ | - | $201,416 | |
| Newport acquisition | 32,241 | - | - | - | - | 32,241 | ||
| Ametherm acquisition | - | - | 11,685 | - | - | 11,685 | ||
| Birkelbach acquisition | - | - | - | - | 777 | 777 | ||
| Impairment of goodwill | (66,487) | - | - | - | - | (66,487) | ||
| Exchange rate effects | - | - | (627) | - | - | (627) | ||
| Balance at December 31, 2024 | $ | - | $96,849 | $55,564 | $25,815 | $777 | $179,005 | |
| Exchange rate effects | - | - | 1,327 | - | 58 | 1,385 | ||
| Balance at December 31, 2025 | $ | - | $96,849 | $56,891 | $25,815 | $835 | $180,390 | |
Note 19 – Goodwill and Other Intangible Assets (continued)
Other intangible assets are as follows:
| December 31, 2025 | December 31, 2024 | |
|---|---|---|
| Intangible assets subject to amortization: | ||
| Patents and acquired technology | $23,615 | $23,160 |
| Capitalized software | 70,753 | 62,158 |
| Customer relationships | 103,665 | 103,813 |
| Tradenames | 22,870 | 23,216 |
| 220,903 | 212,347 | |
| Accumulated amortization: | ||
| Patents and acquired technology | (9,379) | (7,316) |
| Capitalized software | (60,812) | (55,476) |
| Customer relationships | (52,582) | (45,053) |
| Tradenames | (19,643) | (17,279) |
| (142,416) | (125,124) | |
| Net intangible assets subject to amortization | $78,487 | $87,223 |
Amortization expense (excluding capitalized software) was $13,196, $11,684, and $9,916, for the years ended December 31, 2025, 2024, and 2023, respectively.
Estimated annual amortization expense of intangible assets on the balance sheet at December 31, 2025 for each of the next five years is as follows:
| 2026 | $12,474 |
| 2027 | 9,510 |
| 2028 | 8,537 |
| 2029 | 8,315 |
| 2030 | 7,154 |
Note 20 – Related Party Transactions
Vishay Precision Group, Inc.
On July 6, 2010, Vishay completed the spin-off of its measurements and foil resistors businesses into an independent, publicly-traded company, Vishay Precision Group, Inc. ("VPG"). Vishay’s common stockholders received 1 share of VPG common stock for every 14 shares of Vishay common stock they held on the record date, June 25, 2010, and Vishay’s Class B common stockholders received 1 share of VPG Class B common stock for every 14 shares of Vishay Class B common stock they held on the record date.
Following the spin-off, VPG is an independent company and Vishay retains no ownership interest.
Relationship with VPG after Spin-off
Following the spin-off, VPG and Vishay operate separately, each as independent public companies. Vishay has no ownership interest in VPG. However, Ruta Zandman, solely or on a shared basis with Marc Zandman and Ziv Shoshani, control a large portion of the voting power of both Vishay and VPG. Ruta Zandman and Marc Zandman are members of Vishay's Board of Directors. Marc Zandman, Vishay's Executive Chairman of the Board and an executive officer of Vishay, previously served on the VPG Board of Directors until his resignation, effective immediately before the election of directors at the VPG 2025 Annual Meeting of Stockholders. Ziv Shoshani, CEO of VPG and a nephew of Ruta Zandman and a brother of Roy Shoshani, Vishay's Executive Vice President - Chief Operating Officer - Semiconductors and Chief Technical Officer, previously served as a director on the Vishay Board of Directors until his resignation, effective immediately before the election of directors at the Vishay 2025 Annual Meeting of Stockholders. As of December 31, 2025, there are no common board members between Vishay and VPG.
In connection with the completion of the spin-off, Vishay and its subsidiaries entered into several agreements with VPG and its subsidiaries that govern the relationship of the parties following the spin-off. Among the agreements entered into with VPG and its subsidiaries were a transition services agreement, several lease agreements, and supply agreements. None of the agreements have had nor are expected to have a material impact on Vishay’s financial position, results of operations, or liquidity. Some of these agreements have expired and have not been renewed.
Vishay also entered into a trademark license agreement with VPG pursuant to which Vishay granted VPG the license to use certain trademarks, service marks, logos, trade names, entity names, and domain names which include the term “Vishay.” The license granted VPG the limited, exclusive, royalty-free right and license to use certain marks and names incorporating the term “Vishay” in connection with the design, development, manufacture, marketing, provision and performance of certain VPG products that do not compete with any products within Vishay’s product range as constituted immediately following the separation and certain services provided in connection with the products. The license cannot be terminated except as a result of willful misconduct or liquidation bankruptcy of VPG.
This page intentionally left blank.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.